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ABSTRACT
ESPFU, AN ENTEROHEMORRHAGIC E. COLI
SECRETED EFFECTOR, HIJACKS MAMMALIAN
ACTIN ASSEMBLY PROTEINS BY MOLECULAR
MIMICRY AND REPETITION
APRIL 25TH 2014
(CINDY) YUSHUAN LAI
B.A., MOUNT HOLYOKE COLLEGE
Ph.D., UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
Directed by: Professor John M. Leong, MD/PhD
Enterohemorrhagic E. coli (EHEC) is a major cause of food borne diarrheal illness
worldwide. While disease symptoms are usually self-resolving and limited to severe
gastroenteritis with bloody diarrhea, EHEC infection can lead to a life threatening
complication known as Hemolytic Uremic Syndrome (HUS), which strikes children
disproportionately and is the leading cause of kidney failure in children. Upon in-
fection of gut epithelia, EHEC produces characteristic lesions called actin pedestals.
These striking formations involve dramatic rearrangement of host cytoskeletal pro-
teins. EHEC hijacks mammalian signaling pathways to cause destruction of microvilli
and rebuilds the actin cytoskeleton underneath sites of bacterial attachment. Here,
we present a brief study on a host factor, Calpain, involved in microvilli efface-
v
ment, and an in depth investigation on a bacterial factor, EspFU, required for actin
pedestal formation in intestinal cell models. Calpain is activated by both EHEC and
the related pathogen, enteropathogenic E. coli (EPEC), during infection and facili-
tates microvilli disassembly by cleavage of a key membrane-cytoskeleton anchoring
substrate, Ezrin. Actin pedestal formation is facilitated by the injection of two bac-
terial effectors, Tir and EspFU, into host cells, which work in concert to manipulate
the host actin nucleators N-WASP and Arp2/3. EspFU hijacks key host signaling
proteins N-WASP and IRTKS by mimetic displacement and has evolved to outcom-
pete mammalian host ligands. Multiple repeats of key functional domains of EspFU
are essential for actin pedestal activity through proper localization and competition
against the an abundant host factor Eps8 for binding to IRTKS.
vi
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CHAPTER 1
INTRODUCTION
1.1 Acknowledgements
The main body of this introduction starting from section 1.4 is adapted from
a review that I co-authored with Ilan Rosenshine, John Leong, and Gad Frankel
[70]. Sections 1.4.4 and 1.4.5 were penned by Gad Frankel. Figures are professional
redrawings by a Wiley hired artist (Laura Symul) based on original figures.
1.2 EHEC Clinical Disease
Enterohemorrhagic E. coli (EHEC) causes serious diarrheal illnesses worldwide.
Normally found as inconsequential coinhabitants in the gastrointestinal tract of cows
and a variety of ruminants, EHEC can be transmitted to humans by ingestion of
contaminated foods. Disease occurs only in humans and usually begins a few days
after ingestion [117]. Symptoms of EHEC infection, though extremely unpleasant,
usually resolve in one or two weeks and include severe abdominal cramping, watery
diarrhea, hemorrhagic colitis, and bloody diarrhea. However, in an estimated 5-
7% of cases, patients can progress to hemolytic uremic syndrome (HUS), a triad of
hemolysis, thrombocytopenia, and renal failure [46]. Children are disproportionately
susceptible and HUS, which is caused by systemic absorption of Shiga toxin (Stx),
(for review, see [117]). HUS is the leading cause of renal failure in children.
EHEC is relatively new pathogen. First described in 1983, EHEC disease was
once almost exclusively associated with the ingestion of undercooked beef or raw
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dairy [98]. In more recent years however, EHEC outbreaks can be traced to foods
as varied as fresh produce, cookie dough, and prepackaged frozen foods[6, 86]. Most
outbreaks associated with HUS are caused by EHEC serotype O157:H7, though
serotypes causing diarrheal disease and HUS are expanding. The CDC reported two
multistate outbreaks in 2013, together involving 20 states, 68 hospitalizations and 4
cases of HUS [24]. Numerous local outbreaks commonly originating from restaurants
and petting zoos are now documented yearly.
Treatment for EHEC induced diarrhea is limited to supportive therapy as antibi-
otics can increase the risk of HUS. No specific therapies for HUS exist and manage-
ment involves empiric, careful monitoring of fluid levels and kidney function [117].
1.3 Virulence Mechanisms of AE Pathogens
EHEC is a member of the attaching and effacing (AE) pathogen family, which also
includes enteropathogenic E. coli (EPEC), an important cause of infantile diarrhea
in developing countries, and the mouse pathogen Citrobacter rodentium, and the
rabbit pathogen RDEC [33, 113]. EHEC and EPEC are unique among human E.
coli pathovars and other gut pathogens pathogens in that they colonize the intestinal
mucosa via AE lesions that are the defining hallmark of this family [33]. AE lesions
are characterized by effacement of the intestinal brush border, intimate bacterial
attachment to the plasma membrane of infected enterocytes, and accumulation of
electron dense material, consisting of mostly actin filaments, under the extracellularly
bound bacteria [28]. This distinct attachment strategy aids in EHEC and EPEC
pathogenesis.
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1.3.1 The locus of enterocyte effacement (LEE)
EHEC and EPEC have both acquired numerous pathogenecity islands (PAI).
Their defining PAI, called the locus of enterocyte effacement (LEE) is essential for
virulence and the AE phenotype. The LEE encodes a complex bacterial effector
delivery machinery called the type 3 secretion system (T3SS) as well as and key
compenents needed for AE lesions [113, 132].
The T3SS is expressed and upregulated in response to specific, complex extracel-
lular signals inside the gut [46]. Upon contact with host cells, the T3SS injects bac-
terial effectors directly into infected cells in a coordinated manner, thereby providing
EHEC and EPEC intracellular access and exquisite control of infected enterocytes
[132]. In addition to seven effectors encoded on the LEE, EHEC and EPEC strains
possess a wide reperatoir of non-LEE encoded effectors [33, 132]. EHEC injects
about twice as many effectors as EPEC, potentially up to 60 [33, 118]. While many
effectors are as yet uncharacterized, several have been well documented to disrupt a
number of cellular processes often through hijacking of highly regulated cell signaling
cascades.
1.3.2 AE lesions in disease
The ability to form AE lesions is essential in establishing infection and disease.
Numerous studies have now demonstrated that AE pathogens incapable of generating
AE lesions display severe colonization defects and reduced disease phenotypes in
variety of animal models [42, 77, 100, 116, 122, 75]. In addition, EHEC mutants
defective in stimulating actin pedestal formation fail to expand their initial infectious
niche [30, 99, 74].
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1.4 Actin Pedestal Formation Pathways by AE Pathogens
The striking actin rich structures formed on infected cells by EPEC and EHEC
have come to be known as actin pedestals. First visualized in microscopy studies in
cultured cells [98], actin pedestals have been the subject of considerable study for the
last two and a half decades. As seen in figure 1.1, actin rich structures protrude from
the surface of cells infected by AE pathogens, such that the adherent bacteria appear
to be lifted on a pedestal and sometimes cupped by the surrounding actin when
viewed from above. Although these two related pathogens utilize highly homologous
key effectors to promote actin pedestals that are morphologically indistinguishable,
EPEC and EHEC utilize distinct signaling pathways to generate their pedestals.
Studies comparing the two strategies have provided fascinating examples of how
microbial pathogens can hijack related mammalian actin assembly signaling cascades
in multiple ways.
1.4.1 Tir, a unique paradigm for host cell attachment and signaling by
a microbial pathogen
Actin pedestal formation for both EPEC and EHEC requires the delivery of
the LEE encoded effector called the translocated intimin receptor or Tir. Upon
translocation into host cells, Tir inserts into the apical membrane such that the N-
and C-terminal portions of Tir are cytosolic, with helical transmembrane domains
traversing the host apical membrane. The central ( 100-residue) portion, known as
the Intimin Binding Domain (IBD), forms two helices separated by a hairpin loop
on the external surface of the host cell [65, 73]. This loop binds the C-terminus of
intimin, which is expressed on the surface of EPEC and EHEC, with high affinity
(Kd of 10 nM for EPEC and less than 1 nM for EHEC) thus facilitating extremely
tight attachment of these pathogenic E. coli to the host cell [38, 101]. Also encoded
by the LEE, intimins can interchangeably bind Tir from EHEC or EPEC strains.
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In addition to its function as a bacterial receptor, Tir serves as a signaling effector
that elegantly initiates the recruitment of host adaptors and actin nucleators from
inside the host cytosol, a strategy commonly used by intracellular pathogens to
exert pathophysiologic effects. Although EPEC and EHEC Tirs are homologous in
structure and share 60% identity [65] they use divergent mechanisms of signaling that
then converge on the activation of common actin nucleators to produce pedestals that
are indistinguishable when examined by electron microscopy or fluorescence imaging
of actin (Figure 1.1).
Both intimin and Tir appear to be adapted for multimerization. The beta barrel
region of intimin, which anchors intimin to the bacterial outer membrane, and the
IBD of Tir each encode dimerization domains, giving rise to a model in which the
two proteins might efficiently form higher order lattices essential for downstream
signaling [73, 120].
Within an infected host cell, Tir interacts with a number of host proteins through
its N- and C-terminal cytosolic domains. The N-terminal tail is functionally inter-
changeable between EHEC and EPEC Tirs and binds various focal adhesion proteins,
thereby potentially linking Tir to the cytoskeleton [56, 66]. However, such activity
is insufficient for actin pedestal formation [66]. Both EPEC and EHEC require the
C-terminal tail, the portion of Tir that is most divergent between these two highly
related pathogens [38]. Notably, intimin binding enhances post-translocation modi-
fication of the C-terminus of Tir inside the host cell. These modifications, when fully
characterized, were pivotal in revealing the mechanism of actin pedestal formation
[67, 21, 19].
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Figure 1.1: Actin Pedestals
Actin pedestals as visualized by transmission electron microscopy ap-
pear as electron dense protrusions beneath intimately attached bacteria
(A). By immunofluorescence microscopy, actin pedestals can visualized
with phalloidin conjugated fluorophores. EHEC (blue; DAPI stained )
induces actin pedestals on infected HeLa cells (B) and HCT8 intestinal
cells (C) stained with Alexa-488 conjugated phalloidin (green). White
arrowheads point to typical actin pedestals for these cells types. Tir
stained with Alexa-568 (red) colocalizes with actin at the tips of actin
pedestals, forming yellow foci beneath intimately adhered bacteria.
6
Figure 1.1: Actin Pedestals
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1.4.2 EPEC pedestal formation pathways
Host modification of the C-terminus of EPEC Tir is critical for its activity. This
domain contains multiple tyrosine, threonine, and serine residues that are available
for potential host phosphorylation. Serine/threonine phosphorylation, which changes
the apparent molecular weight of Tir by SDS-PAGE from less than 80 kDa to about
90 kDa, has been suggested to play a role in Tir insertion into the apical membrane,
but otherwise does not contribute to actin pedestal formation. Tyrosine phospho-
rylation of EPEC Tir, on the other had, is absolutely required for efficient actin
polymerization [67]. Multiple protein kinases, including members of the Abl and Src
kinase families, have been localized to EPEC pedestal tips and thus implicated in
pedestal formation; broad inhibition of both these classes of kinases by non-specific
pharmacologic inhibitors can inhibit EPEC pedestals [115, 62]. However, EPEC can
still induce pedestal formation on a variety of cultured cells lacking individual ki-
nases from the Abl or Src families, suggesting that EPEC Tir is capable of utilizing
multiple, redundant tyrosine kinases for Tir phosphorylation in vitro [115].
Of the Tir C-terminal tyrosine residues, phosphorylation of residue Y474 (in
EPEC1 strain E2348/69) is the most critical for focal actin assembly and triggers the
major pathway by which EPEC1 strains initiate pedestal formation in vitro (Figure
1.2, pathway 1) [67, 37]. In clinical isolates, this critical residue may be in other
close positions due to small insertions or deletions. This pedestal formation pathway
utilizes the host adaptor Nck, which contains an SH2 domain capable of binding a
12-residue region of EPEC Tir that includes the critical phosphorylated Y474 [58, 18].
Nck, found at the tips of EPEC-induced actin pedestals, also contains three SH3 do-
mains that may directly or indirectly recruit the host actin nucleation promoting
factor, N-WASP [58, 14]. N-WASP, in turn, subsequently recruits and activates the
actin nucleating Arp2/3 complex [111, 79].
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Due to similarities in the use of Nck and N-WASP by vaccinia virus for actin
comet tail formation, a similar mechanism of actin assembly has been proposed for
EPEC [19]. Vaccinia produces A36R, a Nck-binding protein, that, like EPEC Tir,
is tyrosine phosphorylated by the host. An eight-residue sequence in the A36R Nck-
binding region is nearly homologous to the Y474 region of EPEC Tir [19]. Recruitment
of Nck by A36R leads to indirect activation of N-WASP through the intermediary
adaptor, WASP Interacting Protein (WIP) [82]. WIP contains N-terminal proline
rich domains that are capable of binding Ncks SH3 domains; its C-terminal WASP
binding domain (WBD) activates N-WASP by binding to the N-WASP N-terminal
WH1 domain [82]. Ectopic overexpression of the WBD decreases vaccinia actin comet
tail formation, presumably by a dominant negative effect, and various mutations in
the WH1 domain of N-WASP can abrogate its recruitment and actin comet tail
formation by vaccinia [82].
Interestingly, a role for WIP in pathogen-mediated actin assembly appears to
depend on the experimental system. Garber and colleagues showed that both EPEC
and vaccinia are still able to induce actin assembly in a cell line lacking WIP [51].
N-WASP also contains a proline-rich domain that is capable of binding Nck directly,
and thereby leading to its activation [3]. As is the case for the kinases(s) responsi-
ble for EPEC Tir phosphorylation, seemingly disparate observations concerning the
mechanism of N-WASP activation by Nck and the role of WIP may indicate a degree
of redundancy in the N-WASP activation pathway.
Although the major pathway for EPEC pedestal formation requires Nck, Nck-
independent mechanisms of actin pedestal formation have also been uncovered, re-
flecting redundant pedestal formation pathways (Figure 1.2, pathways a and b).
EPEC infection of Nck-deficient murine embryonic fibroblasts still generate roughly
one-fifth the number of the actin pedestals generated upon infection of wild type
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fibroblasts. Most of this activity, also requires Y474, reaffirming its role as a key
residue for triggering actin assembly by EPEC Tir. However, even in the absence
of Y474, about 2-5% of bound EPEC can generate actin pedestals, a rate more than
ten-fold higher than for a Tir-deficient EPEC strain. An additional tyrosine residue
at position 454 of EPEC Tir is critical for this minor Nck-independent actin assem-
bly activity [19]. Initially considered of marginal importance, this pathway was later
shown to be highly related to the major pathway of actin pedestal formation by
EHEC.
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Figure 1.2: EPEC and EHEC Actin Pedestal Pathways
EPEC and EHEC use different mechanisms of Tir activated signaling
cascades that converge on common host actin nucleation factors, N-
WASP and Arp2/3 to form actin pedestals. The major EPEC actin
pedestal pathway requires phosphorylation of the critical Tir residue
Y474, which recruits Nck (pathway 1). Nck can activate N-WASP di-
rectly or through WIP. The major EHEC actin pedestal pathway re-
quires Tir residues NPY458 and the EHEC effector EspFU/TccP (path-
way 2). EspFU/TccP is linked to Tir via host adaptors IRTKS and
IRSp53 and activates N-WASP. Minor EPEC actin assembly pathways
utilize Tir residues Y474 or Y454 to initiate Nck independent activation
of N-WASP (pathways a and b). A minor actin assembly pathway
for EHEC utilizes EspFU, but does not require N-WASP for Arp2/3
activation (pathway c).
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1.4.3 EHEC pedestal formation pathways
A critical first indication that EHEC and EPEC utilized distinct pedestal for-
mation pathways came from studies showing that tyrosine phosphorylated proteins
were absent from EHEC actin pedestals [37]. In fact, EHEC Tir lacks the equivalent
of EPEC Tir Y474, and EHEC does not require Nck for actin pedestal formation
[65, 37]. Consistent with distinct pathways of actin assembly, EHEC tir cannot com-
plement EPEC tir mutants for actin pedestal formation unless modified to encode
the critical Y474-containing region of EPEC Tir [66, 18]. Importantly, co-infection of
cultured Tir and intimin deletion mutants of EPEC and EHEC revealed that EHEC
requires an additional EHEC-specific effector for pedestal formation [66, 37]. These
observations pointed to very different mechanisms of actin pedestal formation for
EPEC and EHEC (Figure 1.2).
Experiments using chimeric Tir proteins suggested that the key to differences
in EPEC and EHEC Tir lie in the C-terminus. While the N-terminus and IBD
of EHEC and EPEC Tir are highly similar and functionally interchangeable, their
cytosolic C-terminal domains are only 41% identical [38]. Further studies of this
region revealed that an NPY sequence at residues 456 to 458 of EHEC Tir is critical
for actin pedestal formation [9]. Interestingly, EHEC Tir residue Y458 corresponds
to EPEC Tir Y454, the residue previously shown to be essential for triggering one of
the minor Nck-independent actin assembly pathways in EPEC pedestal formation,
described above.
Instead of utilizing tyrosine phosphorylation and Nck recruitment, the EHEC Tir
NPY-mediated pathway acts through a different category of host adaptors (Figure
1.2, pathway 2). The NPY458 sequence of EHEC Tir, and likely the equivalent
sequence of EPEC Tir as well, binds to IRTKS and IRSp53, members of the I-Bar
subfamily of membrane deforming and remodeling proteins. These proteins link to
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Tir via their N-terminal IMD domains, which also form zeppelin-shaped homodimers
associated with convex membrane protrusions [125, 128, 34, 137]. The C-terminal
regions of IRTKS and IRSp53 contain additional motifs, such as an SH3 domain, that
link their membrane deforming activity to signaling proteins and actin regulators
[128, 125].
A paradox in this Tir NPY-mediated pedestal pathway is that it promotes pedestal
formation with very low efficiency for EPEC, yet with very high efficiency for EHEC
[19, 16]. This riddle was solved by the identification of an additional non LEE-
encoded bacterial effector, termed EspFU (a homolog of the effector EspF encoded
on prophage U) or TccP (Tir cytoskeleton coupling protein) [20, 53]. Found in ex-
clusively EHEC, EspFU also greatly enhances NPY458 mediated pedestal formation
if expressed in EPEC1 [16] and is essential for actin pedestal activity by EHEC.
EspFU connects the seemingly disparate Tir NPY458 actin assembly pathway back
to N-WASP and Arp2/3; it simultaneously binds IRTKS or IRSp53 and activates
N-WASP. Functional activity is conferred by repeating elements containing a helical
domain that binds activates N-WASP and a proline rich domain that binds IRTKS
[21, 53, 26, 125, 1]. Natural isolates of EspFU contain anywhere from three to eight
repeats [54, 52].
Finally, just as EPEC encodes multiple actin assembly pathways, EHEC triggers
yet another alternative pathway for pedestal formation in a cell culture model (Figure
1.2). Low levels of actin assembly can be observed when embryonic fibroblasts from
N-WASP knockout mice are infected with an intimin-expressing E. coli strain that
delivers EHEC Tir and EspFU/TccP. This N-WASP-independent pathway depends
on multiple repeats of EspFU/TccP, again suggesting a functional role for multiple
repeats [124], but the critical elements of this pathway are yet unidentified.
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1.4.4 TccP2/EspFM-induced actin polymerization in non-O157 EHEC
and EPEC
Typical EHEC O157:H7 also possesses a pseudogene of EspFU/TccP encoded on
prophage CP-933 M/Sp4, and thus called TccP2/EspFM, which lacks an intact type
III secretion signal [89]. Beta-glucuronidase-positive and sorbitol-fermenting EHEC
O157 strains harbor an intact TccP2/EspFM gene as well as an espFU/tccP gene
[89]. Although they carry divergent N-terminal secretion signals, EspFU/TccP and
TccP2/EspFM share the same repeat structure, and EspFU/TccP and TccP2/EspFM
are functionally interchangeable in EHEC O157 strains [90].
Unexpectedly, EspFU/TccP was also found in EPEC strains of the serotype
O119:H6, which express Tir that contains both NPY458 and Y474 equivalents [90].
Infections of cultured cells have shown that EPEC O119:H6 can simultaneously uti-
lize the Tir:Nck and Tir:IRTKS/IRSp53:EspFU/TccP pathways (Figure 1.3) [130].
Later, this infection strategy was found to be common among EPEC strains belong-
ing to the EPEC2 evolutionally lineage and non-O157:H7 strains, as they encode
both a functional TccP2/EspFM and a Tir protein that can be tyrosine phosphory-
lated [129, 89]. These results show the existence of yet another level of redundancy
and suggest that Tir-induced actin polymerization is under strong selective pressure.
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Figure 1.3: Atypical EPEC and non-O157 EHEC can use the major
pathways of both typical EPEC and O157 EHEC to generate actin
pedestals
Tir in these strains contain both an Y474 equivalent, which initiates
actin assembly through Nck (pathway 1), and an NPY458 equiva-
lent, which initiates actin assembly through IRTKS/IRSp53 and an
EspFU/TccP homologue, TccP2/EspFM (pathway 2).
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Figure 1.3: Atypical EPEC and non-O157 EHEC can use the major pathways of
both typical EPEC and O157 EHEC to generate actin pedestals
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1.4.5 Map and EspH impact on Tir-induced actin polymerization
Map and EspH have both been implicated in filopodia formation and modulation
of Tir-induced actin polymerization in undifferentiated epithelial cells. While Map is
a Cdc42 guanine nucleotide exchange factor (GEF) [15], EspH is a RhoGEF inhibitor
that acts by competitively binding to the tandem Dbl-homology and pleckstrin-
homology (DH-PH) domains of Dbl-family mammalian RhoGEFs [41]. Ectopic ex-
pression of EspH leads to cell detachment, while infections with strains either missing
or over-expressing EspH result in short or elongated pedestals, respectively. Impor-
tantly, EPEC infection leads to accumulation of WASP-interacting protein (WIP)
at the tip of the Tir-induced actin pedestals [51, 133] in a process involving EspH,
which itself taggers actin polymerization in a Tir-dependent mechanism [131].
Activation of Cdc42 by Map leads to transient filopodia formation during early
stages of infection; interaction of Map with NHERF1 via its PDZ-biding motif is
needed for filopodia stabilization [5]. Recovery from the filopodial signals requires
phosphorylation of Tir tyrosine Y474 and activation of the actin polymerization path-
way as either infection of Nck-proficient cells with EPEC expressing Tir Y474 or infec-
tion of Nck-deficient cells with wild-type EPEC results in persistence of filopodia [5].
The relevance of these pathways in EPEC-induced mivrovilli effacement was recently
reported following infection of polarized Caco-2 cells [36]. Taken together, these data
show the existence of an elaborated cross talk between Tir and other effectors that
subvert actin dynamics.
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CHAPTER 2
MICROVILLI EFFACEMENT BY EHEC IS CALPAIN
MEDIATED
2.1 Acknowledgements
This chapter is the result of collaborative efforts with the lab of Ira Herman and
published in 2011 [69], with significant contributions by Kathleen Riley and Andrew
Cai. SEM images were collected by Lara Strittmater in the electron microscopy core
at UMMS.
2.2 Introduction
AE pathogens presumably must first dismantle highly organized cell surface struc-
tures, namely microvilli, on the apical surface of gut epithelia prior to pedestal for-
mation. Highly specialized to enhance function of the intestines, microvilli not only
increase the apical surface area of intestinal epithelial by about 30-fold, but serve
as sites of robust transport of water and nutrients [12, 71, 121]. Loss of microvilli
would therefore severely impair absorptive capacity and facilitate diarrheal disease.
And while pedestal formation by AE pathogens has been well characterized, much
less is known about the mechanisms promoting microvillar effacement.
Microvilli are highly organized and uniform. Each microvillus consists of a core
bundle of F-actin that is stabilized internally by villin and fimbrin and tethered
laterally to adjacent plasma membrane by myosin1A:calmodulin cross-bridges. The
bundle is anchored at the base to the terminal web via conventional acto-myosin
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interactions that ultimately associate with the basolateral membrane domain termi-
nating in adherens and tight junctions where adjacent epithelial cells are tethered
to one another [12, 121]. In addition, ezrin, an ERM family protein required for
microvillar development, is found at this apical cytoskeletal-membrane interface of
polarized intestinal epithelia, and is thought to bridge the apical plasma membrane
to microvillar F-actin core [11, 44]. Core microvillar components are also in con-
stant turnover, making microvilli highly dynamic structures [12, 121]. Because of
this, there are several potential host proteins that could be targeted by EHEC to
alter the cytoskeleton and yield AE lesions. Given the complexity and inherent dy-
namic nature of microvilli, AE pathogen-induced microvilli effacement likely involves
participation of key host adaptor proteins, just as pedestal formation does.
An important class of eukaryotic cytoskeletal regulators are the calpains, Ca+2
dependent proteases that cleave a variety of enzymes and regulatory proteins to mod-
ulate cellular function. Calpains are ubiquitously expressed in vertebrates and have
been implicated in many important cellular processes, such as regulation of signal
transduction, cell spreading and motility, membrane repair, cell death, embryoge-
nesis, and tumor suppression [31, 95, 112]. Many reported calpain substrates are
involved in regulating the actin dynamics, especially during cellular adhesion and
migration [25, 48, 68, 72, 95, 107]. Several microbial pathogens, promote disease
through the inappropriate activation of calpain [35, 45, 55, 93, 114, 127, 136]. EPEC
infection results in an increase intracellular Ca+2 levels in mammalian cells[4], and
induces calpain activity in a manner dependent on type III secretion system [35, 61].
Calpain was previously shown to control EPEC-induced enterocyte effacement in
vitro [94].
While calpains roles in effacement and intestinal barrier disruption have been
documented for EPEC, its involvement in EHEC infection has not been character-
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ized. Since comparative analysis of pedestal formation by EPEC and EHEC have
revealed that these related pathogens generate actin pedestals by fundamentally dif-
ferent means [22, 63], we sought to determine if calpain plays an important role in
EHEC effacement, as it does in EPEC [94].
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2.3 Materials and Methods
2.3.1 Cell culture
CaCo-2a enterocytes, stably transfected with the calpastatin high over-expression
plasmid pRC/CMV-3∆CSN (HOX) or the pRC/CMV empty vector (CON), have
been previously described [94]. Cells were grown in Dulbecco’s Modified Eagle’s
Medium supplemented with 10% fetal bovine serum, 1% each penicillin-streptomycin-
fungizone (PSF) and L-glutamine. Sub-confluent cultures were maintained in T175
flasks. For experiments, cultures were washed twice with HBSS, released with
trypsin-EDTA, and seeded at confluence (approximately 1.5 x 105 cells/cm2) in tis-
sue cultures vessels precoated with collagen (BD #354236). CaCo-2a cells were then
allowed to differentiate for 7 to 14 days, and fed every 2 or 3 days. For electron
microscopy, cells were seeded onto standard plastic 6-well, tissue culture plates. For
immunofluorescence staining, cells were seeded into 24-well glass bottom tissue cul-
ture plates (Mattek #P24G-1.5-13F). For calpain activity, cells were seeded into
plastic 96-well black walled tissue culture plates with optically clear bottoms (Ibidi
#89626).
2.3.2 Bacterial culture and infection
Table C.1 lists all bacterial strains used in this study. The wild type, Stx de-
ficient EHEC strain of serotype O157:H7, strain TUV-93 has been previously de-
scribed [18]. In preparation for infection, individual colonies from freshly streaked
plates were grown in 1 mL of LB with appropriate antibiotics for up to 8 hours. 10
mL of this day culture was transferred to DMEM/100mM HEPES/antibiotics and
incubated overnight at 37°C with 5% CO2 to induce T3SS expression. For infection,
bacteria were resuspended in DMEM/2% FBS/20 mM HEPES/2mM glutamine to
the following MOIs: EHEC at 500:1, EPEC at 100:1. Higher MOIs were used for
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EHEC infections because pilot studies indicated that strain TUV-93 does not adhere
to cells as well as EPEC strain JPN15 (data not shown).
2.3.3 Quantification of calpain activity
Calpain activity was assayed using a fluorogenic calpain substrate kit (Anaspec
#72150) specific for calpains 1 and 2. CaCo-2a cell monolayers are seeded in 96-well
TC treated plates with clear bottoms and black walls (Ibidi #89626) 10 to 14 days
prior to use. Cells were infected as described above. Infected monolayers were washed
twice with HBSS. 50 mL of assay buffer was added to each well and incubated at
room temperature for 5 to 10 minutes. Cells were scraped with a pipette tip and 50
mL of fluorogenic substrate in assay buffer was added to each well. Plates were spun
at 1000 rpm (200 x g) on a tabletop centrifuge for 5 minutes to reduce bubbles and
incubated at room temperature in the dark for up to 60 minutes. Fluorescence was
measured using a Molecular Devices SpecraMax Gemini XS at 354 nm excitation
and 442 nm emission and corrected for background fluorescence (i.e. that of wells
with substrate only).
2.3.4 Calpastat treatment
Calpastat, a cell-penetrating calpastatin peptide [32] was synthesized at the Tufts
Peptide Core Facility using solid phase F-moc chemistry. Peptides were purified by
high performance liquid chromatography; molecular mass and purity were confirmed
by mass spectrometry. A 25 mM peptide stock was prepared in 100mM HEPES,
pH 7.4 and stored at -20°C. For treatments, cell monolayers were washed once with
HBSS and cell culture media containing Calpastat at the specified concentrations
was added. Cells were incubated at 37°C in 5% CO2 for 1 hour.
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2.3.5 Scanning electron microscopy (SEM)
Cell monolayers were washed twice with HBSS, then fixed by immersion in 2.5%
glutaraldehyde in 100 mM sodium phosphate buffer (pH 7.2) for a minimum of 2
hours at room temperature. The fixed samples were then washed three times in
the same buffer. Following the third wash, monolayers were dehydrated through a
graded series of ethanol to 100% and then critical point dried in liquid CO2. The
bottoms of the dishes were cut off and using silver conductive paste, the plastic
disks with the cells attached on the surface were affixed to aluminum SEM stubs
and sputter coated with Au/Pd (80/20). The specimens were then examined using
an FEI Quanta 200 FEG MK II scanning electron microscope at 10 Kv accelerating
voltage. Each specimen was systematically observed at 1000x, 2500x, and 5000x at
five separate areas spaced throughout the disk. Representative images at 10,000x
were taken with disks tilted about 30°.
2.3.6 Immunofluorescence microscopy
For indirect immunofluorescence imaging studies, CaCo-2a cells were seeded at
confluence and allowed to differentiate in 24-well glass bottom culture plates (Mattek
#P24G-1.5-13F). At the indicated time points following infection, cells were washed
with warm DMEM, then fixed in 4% formaldehyde/DMEM for 5 minutes at room
temperature (RT). Cells were permeabilized with 0.1% Triton buffer for 90 seconds
at RT, washed 3 times with PBS, and then incubated with the specified primary
antibodies for 1 hour at RT. Primary antibodies used were mouse anti-ezrin (Zymed
# 357300), rabbit anti-O157 (Gibco), and goat anti-O157 (Fitzgerald Industries
#70-XG13). Alexa-flour conjugated secondary antibodies and/or Alexa-488- or 594-
conjugated phalloidin (Invitrogen #A12379 or #A12381) were applied for 45 minutes
at RT. Images were acquired on a Zeiss 200M inverted microscope with a Hamamatsu
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cooled-CCD digital camera (ER) and MetaMorph 7.0 imaging software (Molecular
Devices Corp, PA).
2.3.7 Subcellular fractionation and western blotting
Infected and uninfected cells were washed with warm TBS to remove media and
unattached bacteria. Extraction buffer containing 40mM HEPES pH 7.2, 50mM
PIPES, 75mM NaCl, 1mM MgCl2, 0.5mM EGTA, Protease Inhibitor Cocktail (1:1000,
Sigma), 1mM sodium orthovanadate, and 0.1% Triton detergent was applied to the
cultures, 0.5ml per well of a 6-well plate, and plates were placed on an orbital shaker
at 50 rpm for 10 minutes at room temperature. The extraction buffer was then re-
moved to tubes held on ice. The remaining cellular residue was collected with 200 µL
boiling hot Laemmli sample buffer. All extracts were dialyzed against 4L distilled
water at 4°C for 4 hours with one water change at 2 hours, using SnakeSkin dialysis
tubing, 10K MWCO (Pierce). Dialyzed samples were snap frozen in liquid nitrogen,
lyophilized overnight, and brought up in 200 µL each Laemmli sample buffer. All
samples were boiled for 3 minutes and loaded onto 10% acrylamide gels for SDS-
PAGE, followed by transfer to nitrocellulose membranes. Membranes were stained
for ponceau to confirm equal protein loading, then probed for ezrin using monoclonal
mouse anti-ezrin (Zymed #357300).
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2.4 Results
2.4.1 Calpain activity increases upon EHEC infection
To investigate whether calpain activity is affected by EHEC, we used a calpain-
specific fluorogenic substrate (Suc-LLVY-AMC) to measure calpain activity in ex-
tracts of EHEC-infected, polarized colonic carcinoma CaCo-2a CON cells. Compared
to uninfected cell monolayers, calpain activity increased after three hours of infection
by EHEC (Figure 2.1). Pretreatment of polarized cell monolayers with a cell pen-
etrating calpastatin inhibitor for one hour prior to EHEC infection reduced EHEC
induced calpain activation to near uninfected levels (Figure 2.1).
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Figure 2.1: EHEC increased calpain activity during infection.
Calpain activity was measured with a fluorogenic, calpain-specific sub-
strate (Suc-LLVY-AMC) in lysates of uninfected CaCo-2a cells, or of
cells infected with EHEC for three hours with or without pretreatment
with 5 mM of Calpastat, a calpain inhibitor. Shown are the means (+/-
SE) of 6 determinations.
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Figure 2.1: EHEC increased calpain activity during infection.
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2.4.2 Calpastat, a cell-penetrating calpain inhibitor prevents EHEC-
induced effacement
To assess the role of calpain in EHEC induced effacement, we infected polarized
CaCo-2a CON cells with or without pretreatment with Calpastat, a cell-penetrating
version of the endogenous calpain inhibitor, calpastatin [23, 32]. Scanning electron
microscopy of uninfected control cells revealed distinct microvilli and cellular borders,
although some variation in the density and arrangement of microvilli was observed
(Figure 2.2A, and data not shown).
When CON cells were infected with EHEC and assessed by SEM at low (1000x)
magnification (Figure 2.2) or TEM (data not shown), CON cells suffered severe bleb-
bing and rounding, indicating cellular damage (Figure 2.2B). This apparent toxicity
was not observed after infection with EPEC (Figure 2.2C), in which cell monolayers
looked nearly identical to uninfected monolayers (Figure 2.2A). Pretreatment with
2.5 mM Calpastat for one hour prior to EHEC infection diminished these effects
(Figure 2.2D), suggesting that calpain activity is required for this cellular damage
and raising the possibility that calpain may be critical for EHEC-induced cellular
pathogenesis.
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Figure 2.2: EHEC infection produced additional gross monolayer dam-
age that was diminished by inhibition of calpain.
Uninfected CaCo-2a CON monolayers (A), or monolayers infected for
two hours with EPEC (C) or EHEC, with (D) or without (B) a one-
hour pretreatment with Calpastat (2.5 µM) were visualized by SEM
under 1000x magnification. Scale bars are 100 µm.
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Figure 2.2: EHEC infection produced additional gross monolayer damage that was
diminished by inhibition of calpain.
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Higher magnification assessment of monolayers at 5000x to 10,000x revealed that
a two-hour infection by EHEC resulted in the predicted microvillar effacement (Fig-
ure 2.3B) as compared to uninfected controls (Figure 2.3A). When CON cells were
subjected to a one-hour pretreatment with 2.5 µM of Calpastat prior to EHEC infec-
tion and assessed by 10,000x magnification SEM, most EHEC-bound cells retained
largely intact microvilli (Figure 2.3C), similar in quality to uninfected CaCo-2a CON
monolayers (Figure 2.3A). As expected, the control infection by EPEC in the absence
of Calpastat treatment also revealed effacement (Figure 2.3D).
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Figure 2.3: A cell-penetrating calpain inhibitor prevents microvilli ef-
facement by EHEC.
Uninfected CaCo-2a CON monolayers (A) and monolayers infected for 2
hours with EHEC without (B) or with (C) 1 hour pretreatment with 2.5
µM Calpastat, or infected with EPEC (D) were visualized by SEM at
10,000x magnification with a 30°tilt. Arrows point to bacteria infecting
surface of Caco-2a CON monolayers. Scale bars are 10 µm.
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Figure 2.3: A cell-penetrating calpain inhibitor prevents microvilli effacement by
EHEC.
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2.4.3 Ectopic expression of calpastatin inhibits effacement by EHEC
We previously showed that the calpastatin-overexpressing CaCo-2a cell line, HOX,
for which the pRC/CMV vector-transfected CaCo-2a CON line serves as an appro-
priate wildtype control, resists effacement by EPEC [94]. Like CON cultures, SEM
assessment revealed some cell-to-cell variability with respect to microvillar length
and density (data not shown); microvilli in HOX cells were, intact and in general,
shorter than those observed in CON cells, as previously described [94] (Figure 2.4A).
When stained for F-actin using fluorescent phalloidin, the microvillar F-actin
core bundles of polarized CON and HOX cells appeared as a punctate fluorescent
pattern on the apical surface (Figure 2.4C and 2.4E) when viewed end-on, while
the circumferential belt of F-actin encircling the apical cytoskeletal-membrane do-
main could also be readily distinguished. This apical F-actin staining pattern was
consistent with the pattern of microvilli observed by SEM (Figure 2.3D and Figure
2.4A). In addition, infection of polarized CON cells by EHEC induced the loss of
this punctate fluorescent staining (Figure 2.4D), consistent with the loss of microvilli
observed during EHEC-induced effacement as revealed by high magnification SEM
(Figure 2.3A).
In stark contrast to the effacement of CON cells by EHEC, infected HOX cells
retained their microvillar-associated punctate F-actin fluorescence staining (Figure
2.4F). The retention of microvillar integrity by HOX cells after two hours (Figure
2.4F) or three hours (data not shown) was confirmed by SEM (Fig. 2.4B and data
not shown). These results indicate that ectopic expression of calpastatin and the
concomitant inhibition of calpain renders HOX cells resistant to effacement by EHEC
infection.
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Figure 2.4: The calpstatin overexpressing cell line, HOX, resisted mi-
crovillar effacement by AE pathogens.
Uninfected polarized CaCo-2a HOX monolayers (A) and polarized HOX
monolayers infected for 2 hours with EHEC (B) were visualized by SEM
at 10,000x magnification and with a 30 tilt. Scale bars for SEMs are
10µm. Polarized control CaCo-2a CON (C and D) and calpastatin-
overexpressing CaCo-2a HOX cells (E and F) were stained for F-actin
(red) and EHEC (green) without (C and E) or with infection (D and
F) by EHEC. F-ctin was stained using Alexa-568-conjugated phalloidin;
EHEC were stained with anti-O157 antibody.
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Figure 2.4: The calpstatin overexpressing cell line, HOX, resisted microvillar efface-
ment by AE pathogens.
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2.4.4 The calpain substrate ezrin is cleaved in response to EHEC infec-
tion and lost from microvilli
We have previously shown that calpain-mediated cleavage of ezrin occurs dur-
ing cell spreading and migration, a process that, like effacement, involves extensive
actin remodeling [95, 94, 107]. Given that EHEC induces calpain activity upon in-
fection of mammalian cells, we tested for ezrin cleavage upon infection by EHEC.
Immunoblotting of subcellular fractions of EHEC infected CaCo-2a CON cells re-
vealed ezrin cleavage (Figure 2.5A). The full-length 80 kDa species was detected in
both soluble and insoluble fractions. The cleaved 55 kDa ezrin fragment, which is
not associated with the plasma membrane, was detected at very slight levels in the
soluble fraction of uninfected CON cells. Infection with EHEC increased this pool
of cleaved ezrin. This cleavage product was not observed in uninfected or EHEC-
infected HOX cells, indicating that calpain is required for its generation (Figure
2.5A).
Immunofluorescence staining of ezrin in polarized CaCo-2a CON cells revealed
a punctate pattern at the apical surface almost identical to that of microvilli stain-
ing by phalloidin (Figure 2.5B). This staining pattern is consistent with its role
in linking the plasma membrane to core microvillar actin bundles [44]. To deter-
mine if EHEC-mediated cleavage of ezrin correlated with a change in the cellular
distribution of ezrin, we stained CON cells for ezrin after EHEC infection. Inter-
estingly, the punctate ezrin pattern disappeared throughout the entire infected cell
(Figure 2.5C). This change in localization was dependent on calpain activity, because
calpastatin-overexpressing HOX cells retained their punctate ezrin staining pattern
during infection (Figure 2.5D).
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Figure 2.5: EHEC infection caused calpain dependent loss of mirovillar
ezrin and ezrin cleavage.
Lysates from subcellular fractions of polarized control CaCo-2a CON
and HOX monolayers with and without 6 hour EHEC infection by were
probed for ezrin by western blot. Asterisk (or arrow) indicates the 55
kDa ezrin cleavage product (A). Polarized CaCo-2a CON cells without
(B) and with 6 hour infection by EHEC (C) and EHEC infected po-
larized HOX monolayers (D) were stained for ezrin (green) and EHEC
(red). EHEC was detected by anti-O157 antibody.
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Figure 2.5: EHEC infection caused calpain dependent loss of mirovillar ezrin and
ezrin cleavage.
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2.5 Conclusions
In response to challenge by AE pathogens, intestinal epithelial cells undergo a
coordinated and robust remodeling of the apical membrane-cytoskeletal domain [22,
56, 61]. Highly organized core bundles of actin in the microvilli are disassembled while
the apical membrane conforms to newly synthesized actin pedestals. These structural
alterations likely disrupt overall epithelial cell function and integrity and contribute
to EHEC- and EPEC-induced gasteroenteritis and diarrhea. While the process of
pedestal formation is well characterized, the mechanisms of microvillar effacement
are poorly understood. Previous work indicated that EPEC infection triggers a rise
intracellular Ca+2 in mammalian cells [4], and EPEC-mediated effacement requires
the Ca+2-regulated host protease, calpain [94]. In this study, we showed that EHEC
infection of CaCo-2a cells induces an increase in calpain activity that is required
for EHEC-mediated effacement. By analogy to EPEC, we postulate that type III
secreted effectors play a role in both calpain activation and microvillar effacement
[35, 61].
Effacement likely involves disruption of protein-protein and protein-plasma mem-
brane interactions that contribute to microvillar integrity. Calpain is known to tar-
get a number of cytoskeletal elements, including the ERM family member ezrin
[47, 48, 72, 95, 107], which contributes to microvillar integrity by indirectly linking
the plasma membrane to the axial actin microfilamentous bundles [11, 105, 108].
Another gut pathogen, H. pylori, triggers calpain-dependent cleavage of ezrin in
gastric parietal cells, resulting in redistribution of the protein, distortion of microvil-
lar structure and disruption of apical secretory function [127]. We showed here that
EHEC-mediated effacement of microvilli is accompanied by calpain-dependent cleav-
age of ezrin and loss of its apical localization.
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The targeting of ezrin by AE pathogens is likely to induce widespread changes
in the structure and function of intestinal epithelial cells. EPEC triggers the tran-
sient formation of filopodia that are significantly destabilized by the expression of
a dominant negative ezrin mutant [6]. Ezrin has also has been implicated in the
assembly of junctional complexes [96], and we found that EHEC infection results in
a calpain-dependent redistribution away from cell-cell junctions. This relocalization
may well have functional consequences on epithelial barrier function, given the obser-
vations that the addition of calpain-inhibitory peptides [35] and or the expression of
a dominant negative ezrin mutant [109] diminish EPEC-induced disruption of tight
junctions and trans-epithelial resistance.
More generally, apical and junctional cytoskeletal domains are functionally in-
tegrated: F-actin rich microvillar rootlet structures penetrate the terminal web,
making intimate contact with the circumferentially-disposed array of filamentous
actin, conventional myosins and intermediate filaments, which all join together in
the terminal web at adherens and tight, occluding junctions [10, 43, 87]. Thus, the
ability of AE pathogens to dramatically alter the apical cytoskeleton is likely to in-
duce changes in the basolateral and terminal web-associated cytoskeleton including
the membrane-cytoskeletal interface. Consistent with this notion, EPEC infection is
known to cause the redistribution of many junctional and basolateral domain pro-
teins [59, 60, 84, 85], some of which are recruited to actin pedestals [64, 92]. It will
be of interest to determine whether the requirement for calpain in the redistribution
of ezrin is reflected in a similar requirement for the redistribution of some or all of
these molecules. Finally, we observed EHEC infection of confluent epithelial cell
monolayers resulted in striking cell blebbing and rounding, consistent with a general
disruption of cell adhesion. Although this damage was calpain-dependent, similar
cellular damage was not induced by EPEC, indicating that this manifestation is sep-
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arable from effacement and that features specific to EHEC likely contribute to this
toxicity. And, while EHEC-mediated cell rounding could be specifically linked to
ezrin cleavage, other actin-associated calpain substrates, such as the focal adhesion
protein talin and actin assembly factor cortactin may also be involved in the host
cytoskeletal adaptive responses [47, 48, 72].
In summary, AE pathogens such as EHEC induce a broad range of cytoskeletal
disruption, among them pedestal formation, tight junction disruption and microvillar
effacement. These alterations are predicted to diminish both the absorptive capacity
and the barrier function of intestinal epithelium, thereby contributing to diarrhea,
a major and potentially life-threatening manifestation of disease. The manifold cel-
lular consequences of infection are undoubtedly in part due to diversity of effectors
translocated to the cell [118]. In addition, an emerging picture is that a central mod-
ulator such as calpain, which has the potential to alter many cytoskeletal structures,
may be a conduit through which AE family members, as well as other infectious
agents, exert pleomorphic pathogenic effects.
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CHAPTER 3
MULTIPLE REPEATS OF ESPFU ARE REQUIRED FOR
PEDESTAL FORMATION BY EHEC
3.1 Acknowledgements
The introduction for this chapter is adapted from the review that I co-authored
with Ilan Rosenshine, John Leong, and Gad Frankel [70]. HCT8 cells were a gen-
erous gift from the lab of Beth McCormick (UMMS). Douglas Robbins, formerly
in the Leong Lab (UMMS), assisted with various infection and immunofluorescence
experimets.
3.2 Introduction
Discovered before IRTKS/IRSp53 or the critical NPY548 residues of EHEC Tir,
EspFU/TccP provided structural insights that helped elucidate both the identity of
its linker to EHEC Tir and the mechanism of N-WASP activation. EspFU/TccP
consists of an N-terminal secretion signal, followed by (in nearly all isolates) between
three and eight repeating elements [54, 52]. Each functional repeating unit contains
two structurally and functionally distinct domains, an N-terminal helical section (H)
that binds and activates N-WASP, and a C-terminal proline-rich domain (P) with
two tandem canonical SH3 binding PxxP motifs that are recognized by the SH3
domain in the C-terminus of IRTKS or IRSp53 [52, 26, 1] (figure 3.1).
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Figure 3.1: Diagram of EspFU structure
EspFU consists of an N-terminal T3SS signal sequence followed by mul-
tiple functional repeating units of helical, N-WASP activation domains
(H) and proline rich, IRTKS binding domains (P). Amino acid se-
quences for the laboratory ”full length” EspFU and the constructed
three repeat EspFU are shown, including the 5 myc tag. Bolded amino
acids at L12 and W33 in each repeat of the three repeat EspFU indicate
positions used for single alanine point mutations.
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Figure 3.1: Diagram of EspFU structure
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EspFU/TccP acts through structural mimicry and, remarkably, has evolved to
outcompete some endogenous host ligands, making it a most efficient hijacker of
mammalian signaling pathways. The H domain of EspFU is structurally similar to
an amphipathic helix in N-WASP’s VCA domain. The VCA domain, which functions
to activate Arp2/3, is normally maintained in an autoinhibited state by binding of
the amphipathic helix to a hydrophobic groove in another domain of N-WASP, the
GBD [111, 79, 26]. Endogenous N-WASP activators such as Cdc42 bind the GBD
to disrupt this autoinhibition indirectly by altering the GBD structure [111, 79]. In
contrast, EspFU’s H domain can bind the GBD in the exact same hydrophobic groove
and directly displace the VCA from the GBD, thereby activating N-WASP [26].
Likewise, the P domains of EspFU act by mimicking natural host proteins. SH3
domains are an abundant and common motif for facilitating cellular interactions and
scaffolding proteins. The P domains of EspFU carry two PxxP motifs, commonly
found in mammalian ligands of SH3 domains and recognize the SH3 domain of IRTKS
with a higher affinity than some of its natural ligands [1]. This enhanced binding
affinity may allow EspFU to better recruit IRTKS, stealing it away from its natural
locales and binding partners within the host cell.
In vitro structural studies show that one single EspFU repeat is capable of ac-
commodating both the GBD of N-WASP and the SH3 domain of IRTKS without
spatial hinderance [54]. However, it is worth noting that more than 99% of EspFU
alleles possess at least three repeats of the functional (i.e. H and P) domains, sug-
gesting that multiple repeats confer a selective advantage to EHEC [54]. Two repeats
of EspFU have been shown to synergistically enhance activation of Arp2/3 in vitro
[17, 104] through enhanced recruitment of Arp2/3. Arp2/3 is a large multimeric
complex that can accommodate two N-WASP proteins [91]. The enhanced actin
assembly activity in vitro by two EspFU repeats (HPHP) is due to the scaffolding of
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two N-WASP proteins into close proximity by the H domains, which is better able to
bind Arp2/3. A single repeat (HP), able to recruit only one N-WASP protein, was
less able to recruit and activate Arp2/3. This in vitro study makes a compelling case
for the advantages of multiple EspFU repeats. However, the upstream components
of pedestal formation, namely IRTKS and Tir have not been studied in regards to
this aspect of EspFU’s repeat structure. The ability to recruit actin assembly ma-
chinery by avidity is potentially enhanced by the fact that IRTKS and Tir both
form homodimers. In addition, dimerization of intimin on the surface of EHEC adds
another layer of multimer formation. EHEC may be using a strategy of multimeric
complexing through both bacterial and mammalian components not only to hijack
essential actin assembly components, but also to concentrate these normally tightly
regulated components to sites of bacterial contact in order to enhance attachment
to the colonic epithelium.
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3.3 Materials and Methods
3.3.1 Cell Culture
HeLa cells were cultured in DMEM supplemented with 10% fetal bovine serum
(FBS), penicillin-streptomycin, and 2mM L-Glutamine. Cells were passed when
confluent. For immunofluorescence experiments, HeLa cells were washed with PBS,
lifted with trypsin-EDTA, and seeded onto #1.5, 12 mm coverslips in 24-well tissue
culture plates 12-18 hours before infection.
HCT8, a human intestinal adenocarcinoma cell line, generously provided by the
lab of Beth McCormick, were cultured in RPMI 1640 (Invitrogen) supplemented
with 10% FBS, 25 mM HEPES, penicillin-streptomycin, and 2mM L-Glutamine.
Subconfluent cultures were maintained at below 80% confluence. For experiments,
HCT8 cells were washed twice with HBSS, once with trypsin-EDTA, incubated with
trypsin-EDTA for 5 to 10 minutes at 37°C, and seeded onto collagen coated tissue
culture vessels. For non-polarized cell conditions, cells were seeded onto collagen
(BD #354236) coated #1.5, 12 mm coverslips in at approximately 100,000 cells/cm2
for 50% confluence or 2.5 x 105 cells/cm2 for 100% confluence. For polarized cell
conditions, cells were seeded at confluence (approximately 2.5 x 105 cells per cm2)
onto collagen coated polyester transwells with 3.0 µm pores (Coring # 3462) and
allowed to differentiate for 5 to 6 days.
3.3.2 Bacterial strains
Table C.1 lists all bacterial strains used in this work. TUV-93.0, a clinical EHEC
isolate with both STX toxin phages removed was used at the background EHEC
strain [18]. TUV-93.0 ∆dam strains were generated by λ red recombineering as
described in [83] to increase infectivity of TUV93.0 on polarized HCT8 cells. Mutants
were screened by PCR. Primers and plasmids used for recombineering are listed in
tables C.2 and C.3.
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3.3.3 Mutation of EspFU
The EspFU truncation mutants HP, HPH, PHP, HPHP, and HPHPH were gener-
ated by restriction digestion of previously constructed mammalian expression plas-
mids and ligation into pDV48, a bacterial expression plasmid containing the N-
terminal T3SS signal sequence of EspFU, followed a short MCS containing KpnI and
BamHI restriction sites, and a 5-myc tag. The sequence for 3 repeats (HPHPHP)
(figure 3.1) was ordered as a mini-gene from IDT with flanking Kpn I and BamHI
sites. All inserts were cloned into the pDV48 in between KpnI and BamHI.
PHPHP, PH*PHP, PHPH*P, and the series of mutants based on HPHPHP were
generated by SLIM PCR mutagenesis according to [27] using Platinum Pfx (Invitro-
gen #11708013) or Phusion (NEB #M0530S) high fidelity polymerases. Tables C.2
and C.3 list all primers used for SLIM and product plasmids generated respectively.
All plasmid constructs were confirmed by sequencing.
3.3.4 Infection
In preparation for infection, 1 mL of LB with appropriate antibiotics were inoc-
ulated with strains from single colonies from plates that were less than two weeks
old and incubated at 37°C on a rotating wheel for up to 8 hours. 10 µL of this
”day culture” was transferred to DMEM/100mM HEPES/antibiotics and incubated
overnight, standing at 37°C with 5% CO2 to induce T3SS expression. Overnight
cultures were then diluted 1/5 to 1/6 in fresh DMEM/100 mM HEPES and grown
to mid-log on a wheel at 37°C. Cultures were collected for use between an OD600
of 0.5 to 0.6. For infection, bacteria were then resuspended in DMEM/2% FBS/20
mM HEPES/2mM glutamine (”FAS media”) to the following MOIs: EHEC at 1:10
to 1:50 for cells on coverslips and 1:100 to 1:200 for cells in transwells. Cells seeded
in coverslips were infected with 500 µL of bacteria resuspended in FAS media. Cells
seeded in 12-well transwells were infected with 200 µL of resuspended bacteria api-
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cally (top/inner transwell) with 1 mL of FAS media in the bottom/outer well. In-
fected cells were then spun at low speed (200 x g) for 10 minutes at room temperature
to facilitate settling of bacteria onto cell monolayers. Infected cells were incubated
at 37°C with 5% CO2 for 5 to 6 hours.
3.3.5 Congo red induction of T3SS effectors
Bacteria were grown in the same manner as in preparation for infections. 5 mL
of mid-log cultures in DMEM/100 mM HEPES were spun down and resuspended in
1 mL of PBS with 20 µm congo red. Bacteria were incubated on a wheel at 37°C
for and additional hour. Bacteria were spun down at 5000x g. Bacterial pellets and
congo red solution with secreted T3SS effectors were collected separately. Effector
proteins were precipitated from congo red solutions by addition of 20% TCA per
volume and incubation at 4°C overnight. TCA precitipated proteins were spun down
at 14,000 rpm at 4°C for 30 minutes and washed once with 500 µL acetone. After
a 10 minute spin at 14,000 rpm at 4°C, removal of acetone and air drying at room
temperature, samples were boiled in equal volumes of 1x SDS laemmli dye, run on
SDS-PAGE, and probed for myc to confirm secretion of myc-tagged EspFU mutants.
3.3.6 Immunoflourescence and imaging
During the last half hour of infection, bacterial cells were ”pre-stained” with
DAPI. Briefly, cells were washed twice apically with warm FAS media. A 1:200 DAPI
solution in FAS media was gently pipetted onto the apical surface (inner chamber
of transwell) of infected cells. Cells were incubated for and additional 30 minutes at
37°C with 5% CO2.
Infected cells were then processed for routine immunofluorescent staining. Cells
were washed twice with warm HBSS (HCT8 cells) or PBS (all other cells), fixed in
4% paraformaldehyde in PBS for 25 to 30 minutes standing at room temperature,
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washed twice with PBS, permeabilized with 0.1% triton X-100 in PBS for 5 minutes
with gentle rocking at room temperature and washed twice again with PBS. Each
wash was performed with gentle rocking for 2 to 5 minutes at room temperature.
Samples were incubated in primary antibody solutions, made in sterile 1% BSA
in PBS, with gentle rocking for 1 hour at room temperature or overnight at 4°C.
Samples were washed twice in PBS before incubation with secondary antibodies and
Alexa-fluor conjugated phalloidin at 1:400 in 1% BSA in PBS for 1 hour at room
temperature with gentle rocking. For some experiments, primary antibodies were
directly conjugated to Alexa-Fluors using APEX Alexa-Fluor antibody labeling kits
(Invitrogen #A10494, #A10475) according to manufacturer instructions. Table C.4
lists all antibodies used in this work and their concentrations . Adobe Photoshop,
ImageJ, and Volocity were used for general image processing.
Images were acquired on a Leica SP5 scanning confocal microscope (200 Hz, frame
averaged 4 times, at 0.21 µm steps), Ziess Axiovert 200M with Apotome attachment
(0.22 µm steps), or Deltavision deconvolution microscope system (0.22 µm steps).
Laser power, gain, offset, and exposure levels were adjusted to positive controls and
fixed for acquisition of images for each experiment. Volocity (Perkin Elmer) and
Photoshop (Abode) were used for general image processing.
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3.4 Results
Expression and T3SS secretion of all myc tagged EspFU constructs from comple-
mented EHEC strains were confirmed by Congo red T3SS induction assay (data not
shown).
3.4.1 PHP is the minimum EspFU requirement for actin pedestal activity
in non-polarized cells
To investigate whether multiple EspFU repeats enhanced actin pedestal activity
in infected cells, truncations of EspFU were cloned and used to complement an EHEC
∆EspFU strain.
While one repeat of EspFU is sufficient to bind both the SH3 domain of IRTKS
and the GBD of N-WASP in vitro [26, 104], it was not able to generate pedestals when
delivered into cultured cells by infection. Figure 3.2 shows HeLa cells infected with
EHEC ∆dam ∆espFU, complemented with various truncation mutants of EspFU up
to 3 full repeats and a wildtype EspFU construct, consisting of six and a half repeats.
(for sequences, see figure 3.1). Actin pedestals appear as distinct concentrations of
actin next to or underneath intimately bound bacteria. When able to generate
pedestals, Myc tagged EspFU constructs are localized as distinct foci at pedestal
tips immediately beneath attached bacteria.
An EspFU construct with an additional H domain following one repeat (HPH) did
not allow for pedestal formation. However, a construct with an additional P domain
preceeding a repeat (PHP) did produce pedestals that were indistinguishable from
pedestals formed by wildtype EspFU. EspFU constructs containing two (HPHP) or
three full repeats (HPHPHP) also made wildtype-like pedestals upon infection of
HeLa cells.
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Figure 3.2: The minimal EspFU repeat requirement for pedestal for-
mation is PHP.
HeLa cells infected with EHEC ∆dam ∆espFU strains complemented
with truncation mutants of EspFU or full length EspFU (last row) were
stained for bacteria (blue), tagged EspFU construct (red), and actin
(green).
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Figure 3.2: The minimal EspFU repeat requirement for pedestal formation is PHP.
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3.4.2 At least 3 repeats of EspFU are needed to generate pedestals in
polarized intestinal cells
While HeLa cells have been a mainstay of cultured cell models for decades, they
may lack proteins, signaling pathways, or structures that are found in gut epithe-
lia. Several existing intestinal cell lines can be induced to form more physiologically
relevant monolayers which may be more appropriate for the study of gut pathogens
such as EHEC. Cell lines such as T84, Caco-2, and HCT8 can be cultured in tran-
swell supports, porous membranes that hang within wells of media, which induce
differentiation of these cell lines to organize and produce structures that are more
characteristic of intestinal epithelia. HCT8 cells were chosen as our model for study-
ing pedestal formation for their ease of culture, minimal time for polarization, and
lack of true mirovilli, which would eliminate the need for effacement. After polar-
ization for 5 to 7 days in 3.0 µm polyester transwells, HCT8 monolayers adopt a
honeycomb-like arrangement with apical and basolateral surfaces that can be clearly
seen upon actin staining.
HCT8 cells were polarized as described in materials and methods and infected
with EHEC ∆dam ∆espFU strains complemented with various truncation mutants
of EspFU. The minimal pedestal competent EspFU construct in HeLa cells, PHP,
does not allow for pedestal formation in polarized HCT8 cells; three full repeats
are now required to generate pedestals (figure 3.3). HPHPHP was able to generate
pedestals that were similar to those produced by full-length EspFU. Of the bacte-
ria attached for these two pedestal competent strains, only a minority of bacteria
generated pedestals.
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Figure 3.3: A minimum of 3 EspFU repeats are required for actin
pedestal formation in polarized HCT8 cells
Polarized HCT8 cells infected with EHEC ∆dam ∆espFU comple-
mented with truncation mutants of EspFU or full length EspFU (last
row) were stained for bacteria (blue), tagged EspFU construct (red),
and actin (green).
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Figure 3.3: A minimum of 3 EspFU repeats are required for actin pedestal formation
in polarized HCT8 cells
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The difference in the EspFU repeat requirement could be a reflection of the change
in cell type. To investigate this phenotype difference, HCT8 cells were seeded onto
collagen coated coverslips at subconfluence (roughly 50% or 100,000 cells per cm2)
and confluence (roughly 100% or 250,000 cells per cm2) and infected the next day.
EHEC ∆dam ∆espFU complemented with PHP were able to generate actin pedestals
in HCT8 cells at subconfluence, as were strains complemented with HPHP and
HPHPH. Interestingly, when HCT8 cells were seeded at confluence, the cell mono-
layer adopted a honeycomb-like arrangement similar to that of HCT8 cells polarized
on transwells. Confluent HCT8 cells in this state also required at least 3 repeats of
EspFU for actin pedestal formation (figure 3.4). In areas where the confluent mono-
layer was discontinuous, PHP was able to generate pedestals only in cells at edges
of the monolayer.
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Figure 3.4: HCT8 cell confluence affects EspFU repeat requirements for
pedestal formation
HCT8 cells seeded onto coverslips at subconfluence (50%) and conflu-
ence (100%) were infected with EHEC ∆dam ∆espFU complemented
with PHP. Infected cells were stained for bacteria (blue), tagged EspFU
construct (red), and actin (green). The bottom image shows an area at
an edge of a confluent HCT8 monolayer. White arrows point to bacteria
producing actin pedestals on cells at and edge of the monalayer. White
arrowheads point to bacteria attached to areas of confluent HCT8 that
are unable to generate actin pedestals.
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Figure 3.4: HCT8 cell confluence affects EspFU repeat requirements for pedestal
formation
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3.4.3 Both H and P domains are necessary for actin pedestal formation
in infected cells
Previous work in our lab [110] and by Sallee et al [104] have identified key amino
acid residues within the H and P domains of EspFU which are required for binding
to the GBD of N-WASP and the SH3 domain of IRTKS respectively. Within the
H domains, alanine mutations at positions V4, L8, or L12, residues which face into
the VCA binding pocket of N-WASP’s GBD, can individually abrogate binding to
N-WASP.
Within each P domain, mutation of the prolines in either of the two tandem PxxP
motifs, can disrupt binding to the IRTKS SH3. Mutation of a critical W residue at
position 33 in between the two tandem PxxP’s can also significantly disrupt binding
[2, 110].
To further investigate the nature of the requirement for EspFU repeats in actin
pedestal formation, a series of mutants based on the three repeat construct HPHPHP
was generated using the L12A mutation to disrupt binding and activation of N-WASP
and the W33A mutation to disrupt binding and recruitment by IRTKS. Domains
carrying these point mutations are indicated by *.
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Figure 3.5: Both H and P domains are required for actin pedestal
activity in polarized HCT8 cells
Polarized HCT8 cells infected with EHEC ∆dam ∆espFU strains com-
plemented with HPHPHP, H*PH*PH*P or HP*HP*HP* were stained
for bacteria (blue), tagged EspFU construct (red), and actin (green).
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Figure 3.5: Both H and P domains are required for actin pedestal activity in polarized
HCT8 cells
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Sufficient binding activity of both the H and P domains to N-WASP and IRTKS
respectively are required for pedestal formation. When all three H domains of
HPHPHP are mutated, the construct (H*PH*PH*P) was unable to generate actin
pedestals in infected polarized HCT8 cells. The construct itself can be recruited
to sites of bacterial attachment, appearing as distinct foci closely associated with
bound bacteria. However, actin is not organized around these foci, indicating that
the three point mutations in the H domains have not activated N-WASP (Figure 3.5).
The presence of the W33A mutation in all three repeats (HP*HP*HP*) prevents re-
cruitment of the construct, thus preventing actin organization at sites of bacterial
attachment. No foci are seen associated with attached bacteria in polarized HCT8
monolayers infected with EHEC ∆dam ∆espFU complemented with HP*HP*HP*.
3.4.4 Only one active H domain is needed for pedestal formation
The H and P domains of each EpsFU repeat serve distinct and separate functions.
Are multiple units of each domain also required to form actin pedestals in polarized
HCT8 monolayers?
To investigate the requirement for the H domains, polarized HCT8 cells were
infected with EHEC ∆dam ∆espFU strains complemented with various 3 repeat
constructs with the L12A mutation in one or two H domains. All constructs were
able to generate pedestals in polarized HCT8 cells, regardless of the position of the
H* mutation or mutations within the three repeats (Figure 3.6).
In non-polarized cells (HeLa, or subconfluent HCT8), all mutants also generated
pedestals as robustly as the fully fuctional 3 repeat construct, HPHPHP (Table 3.1).
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Figure 3.6: One H domain is sufficient to generate actin pedestals in
polarized HCT8 cells
Polarized HCT8 cells infected with EHEC ∆dam ∆espFU strains com-
plemented with mutants of HPHPHP containing one or two L12A mu-
tations in H domains were stained for bacteria (blue), tagged EspFU
construct (red), and actin (green).
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Figure 3.6: One H domain is sufficient to generate actin pedestals in polarized HCT8
cells
67
3.4.5 Multiple P domains are required for pedestal formation
To investigate the requirement for the P domains, polarized HCT8 cells were
infected with EHEC ∆dam ∆espFU strains complemented with various 3 repeat
constructs with the W33A mutation in one or two P domains. A mutation in any
one of the P domains prevents pedestal formation in polarized HCT8 cells.
In non-polarized cells (HeLa, or subconfluent HCT8), all mutants with 2 func-
tional P domains in any position were able to generate pedestals as robustly as the
fully fuctional 3 repeat construct, HPHPHP. Mutants with only one functional P
domain in any position were able to generate pedestals with much less efficiency.
An EspFU construct of less than 3 full repeats was able to generate actin pedestals
in polarized HCT8 cells if it contained three functional P domains and at least one H
domain. Pedestals were apparent in cells were infected with EHEC ∆dam ∆espFU
strains complemented with a PHPHP (Figure 3.8). Variants of this construct bearing
one L12A mutation in either H domain were also able to form actin pedestals. In
contrast, the mutant HPHPH was not able to generate actin pedestals.
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Figure 3.7: 3 Functional P domains are required to generate actin
pedestals in polarized HCT8 cells
Polarized HCT8 cells infected with EHEC ∆dam ∆espFU strains com-
plemented with mutants of HPHPHP containing one or two W33A
mutations in P domains were stained for bacteria (blue), tagged EspFU
construct (red), and actin (green).
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Figure 3.7: 3 Functional P domains are required to generate actin pedestals in po-
larized HCT8 cells
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Figure 3.8: PHPHP but not HPHPH is able to generate actin pedestals
in polarized HCT8 cells
Polarized HCT8 cells infected with EHEC ∆dam ∆espFU strains com-
plemented with HPHPHP (top row) or two and a half repeat versions of
EspFU were stained for bacteria (blue), tagged EspFU construct (red),
and actin (green).
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Figure 3.8: PHPHP but not HPHPH is able to generate actin pedestals in polarized
HCT8 cells
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3.4.6 P domain mutants show partial pedestal activity in non-polarized
cells
Actin pedestals can be observed in HeLa cells infected with EHEC ∆dam ∆espFU
strains complemented with HPHPHP constructs with two W33A mutations, leaving
one functional P domain (Table 3.1). Infection with these strains result in an at-
tenuated pedestal phenotype. About half of the attached bacteria have EspFU foci
underneath sites of bacterial attachment, indicating recruitment of the EspFU mu-
tant; about half of these bacteria with EspFU foci form pedestals. This implies that
P domains with W33A mutations may have residual activity.
Table 3.1: Actin Pedestal Assembly in HeLa Cells
Strain EspFU Foci Pedestals
EHEC∆dam ∆espFU No No
EHEC∆dam ∆espFU + HP No No
EHEC∆dam ∆espFU + HPH No No
EHEC∆dam ∆espFU + PHP Yes Yes
EHEC∆dam ∆espFU + HPHP Yes Yes
EHEC∆dam ∆espFU + HPHPH Yes Yes
EHEC∆dam ∆espFU + HPHPHP Yes Yes
EHEC∆dam ∆espFU + EspFU Yes Yes
EHEC∆dam ∆espFU + H*PHPHP Yes Yes
EHEC∆dam ∆espFU + HPH*PHP Yes Yes
EHEC∆dam ∆espFU + HPHPH*P Yes Yes
EHEC∆dam ∆espFU + HPH*PH*P Yes Yes
EHEC∆dam ∆espFU + H*PHPH*P Yes Yes
Continued on the next page
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Strain EspFU Foci Pedestals
EHEC∆dam ∆espFU + H*PH*PHP Yes Yes
EHEC∆dam ∆espFU + HP*HPHP Yes Yes
EHEC∆dam ∆espFU + HPHP*HP Yes Yes
EHEC∆dam ∆espFU + HPHPHP* Yes Yes
EHEC∆dam ∆espFU + HPHP*HP* Yes Atten.
EHEC∆dam ∆espFU + HP*HPHP* Yes Atten.
EHEC∆dam ∆espFU + HP*HP*HP Yes Atten.
EHEC∆dam ∆espFU + HP*H*P*H*P Yes Atten.
EHEC∆dam ∆espFU + HP*HP*HP* No No
EHEC∆dam ∆espFU + H*PH*PH*P Yes No
3.4.7 IRTKS is recruited to sites of bacteria attachment independently
of EspFU
With the exception of H*PH*PH*P, pedestal incompetent constructs of EspFU
appear to not be recruited to sites of bacterial attachment during infection. For
EHEC strains complemented with a number of pedestal incompetent mutants (not
all were tested), staining for Tir and IRTKS showed that these two upstream pedestal
components are clearly localized to nearly every attached bacteria (figure 3.9). IRTKS
is able to localize to Tir independently of EspFU. These results indicate that pedestal
incompetent mutants with W33A mutations in the P region do not prevent recruit-
ment of IRTKS or Tir to sites of bacterial .
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Figure 3.9: IRTKS recruitment to sites of bacterial attachment does
not depend on EspFU.
Polaized HCT8 cells infected for 3 hours with EHEC ∆dam ∆espFU
complemented with pedestal incompetent PHP were stained for at-
tached bacteria (blue), Tir (red) IRTKS (yellow), and actin (green).
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Figure 3.9: IRTKS recruitment to sites of bacterial attachment does not depend on
EspFU.
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3.5 Conclusion
While one repeat of EspFU can spatially accommodate both the GBD of N-WASP
and the SH3 domain of IRTKS in vitro and theoretically trigger the Arp2/3 actin
assembly cascade [2], it appears unable to generate actin pedestals when delivered
into mammalian cells by infection. Based on studies by Campellone et al. [17], an
additional H domain might facilitate recruitment of actin assembly machinery by
pulling two N-WASP proteins into close proximity, thus enhancing recruitment of
Arp2/3 [91]. Surprisingly, this construct, HPH, was also unable to generate actin
pedestals in infected cells and appears not to be recruited to sites of EHEC attach-
ment. However, an equivalent length construct with one H and two P domains (PHP)
was able to form actin pedestals in non-polarized cells and is cleared localized to the
tips of pedestals underneath bound bacteria. While the previously mentioned in
vitro studies have provided important biophysical insights, our observations indicate
a more complex picture in infected cell culture models.
Polarized epithelia display obvious structural differences from non-polarized cells
that facilitate the specialized physiological functions needed from this type of cell
layer. Polarization of HCT8 intestinal cells results in a different phenotype for the
minimum domains of EspFU required for actin pedestal formation. Whereas non-
polarized cells required a minimum of two P domains, at least three were needed in
polarized HCT8 cells. Though HCT8 cells do not develop robust or well organized
microvilli, organization of actin and other cytoskeletal proteins at the apical surface
may nonetheless hinder the ability of shorter EspFU constructs from functioning.
Actin pedestal activity is dependent on the recruitment of EspFU to sites of bacte-
rial attachment. Except for H*PH*PH*P, all pedestal incompetent EspFU constructs
were not localized underneath intimately bound bacteria. Immunofluorescent stain-
ing of IRTKS and Tir show that these upstream components of the EHEC actin
77
pedestal pathway are able to localize the sites of bacterial attachment in the absence
of EspFU (data not shown) or with pedestal incompetent EspFU mutants. This indi-
cates that the lack of EspFU recruitment is not due to a defect in IRTKS localization
and that IRTKS recruitment to Tir does not depend on binding to EspFU.
The H domains do not appear to play a role in recruitment of EspFU to IRTKS
in our infection model. H domains alone have been shown to polymerize actin in
vitro in the presence of N-WASP and Arp2/3 [104]. Despite having up to three fully
functional H domains, the construct HP*HP*HP*, and other pedestal incompetent
truncation constructs with wildtype H domains (HP and HPH in non-polarized cells;
HP, HPH, PHP, HPHP, HPHPH in polarized cells), were unable to produce actin
pedestals in infected cells. On immunofluorescent staining, these pedestal incompe-
tent constructs also were not localized to any particular location, and aberrant actin
assembly activity was not readily observed within infected cells. Though in vitro
studies have shown an enhancement of actin assembly with two H domains over one
H domain [17], it is unclear wether this enhancement affects recruitment of EspFU to
sites of bacterial attachment. Unfortunately, our infection model is not well suited
to address the exact degree of benefit gained by additional H domains in EspFU
recruitment to the IRTKS/Tir complex underneath intimately attached EHEC.
The P domains target EspFU to IRTKS [125] and this activity does not depend
on the function of the H domains. Even without N-WASP activating activity, the
construct H*PH*PH*P can localize to sites of bacterial attachment in both non-
polarized and polarized cells. It is interesting to note that three repeat constructs
with one wildtype P domain have partial actin pedestal activity in non-polarized cells.
Furthermore, the construct HP*H*P*H*P displays partial actin pedestal activity
comparable to those constructs with no mutations in the H domains but W33A
mutations in two P domains (HPHP*HP*, HP*HPHP*, and HP*HP*HP). Given
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that we see no discernible differences in actin pedestal activities in polarized cells
between three repeat constructs with L12A mutations in one or two H domains,
HP*H*P*H*P might be thought of as being comparable to HP in that both of these
constructs have one wildtype H and one wildtype P domains. However, the partial
recruitment and actin pedestal activity of HP*H*P*H*P on non-polarized cells would
suggest that the W33A mutations in EspFU’s P domains may not abrogate binding
to binding to IRTKS’s SH3 domain completely. And in a cellular environment that
is more permissible to EspFU recruitment to sites of bacterial attachment at the
membrane, these partially active P domains may still contribute to binding to IRTKS.
Thus, recruitment and concentration of EspFU via P domains to the IRTKS/Tir
complex is essential for hijacking the host cell actin assembly machinery for actin
pedestal formation. If an EspFU construct has enough fully functional P domains
to be recruited to IRTKS/Tir, one functional H domain is enough to generate actin
pedestals. While this result seems contradictory to the in vitro observations made
by Campellone and co-workers [17], the concentration of multiple single active H
domains to IRTKS may produce the same structural effect of pulling pairs of N-
WASP proteins within close enough proximity to enhance Arp2/3 activation.
Our results match well with the observation that EspFU’s in nature nearly always
have at least three functional repeats [54]. Multiple repeating H and P domains may
have evolved to overcome the challenges of inducing dramatic rearrangements of
cytoskeletal proteins in a subcellular location that is already highly organized and
regulated. Additional repeats may also confer further selective advantage for EHEC
strains in colonizing gut epithelia. Although EHEC expresses type IV pili, it does not
express bundle forming pili, a potent bacterial adhesin found on the surface of EPEC
[33], and our laboratory experience has shown that 10 to 100 fold higher MOI’s are
needed for EHEC infection over EPEC infection in cultured cells. EHEC may have
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needed to evolve a more enhanced system of intimate attachment to compensate
for lower overall binding efficiency of its other surface adhesins. Through utilizing
additional host and bacterial factors that can dimerize and bind multiple partners,
EHEC’s mechanism of actin pedestal may facilitate enhanced attachment through
multimeric complexing of proteins that link Tir to the cytoskeleton.
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CHAPTER 4
ESPFU COMPETES WITH THE HOST PROTEIN EPS8
FOR IRTKS BINDING
4.1 Acknowledgements
Experiments and figures in sections 4.4.1 and 4.4.2 where executed by Stacie
Clark in the Leong Lab under supervision. Lentiviral transduction was performed
with the assistance of Abe Brass (UMMS) and Chris Louissaint of the McCormick
lab (UMMS). HCT8 cells and Eps8-/- cells were generous gifts from the labs of
Beth McCormick (UMMS) and Giorgio Scita (FIRC Institute of Molecular Oncology
Foundation and the Department of Experimental Oncology of the European Institute
of Oncology, Milan, Italy) respectively.
4.2 Introduction
Like the H domain, EspFU’s P domains may have evolved to outcompete en-
dogenous host ligands and function by mimetic displacement of native intracellular
protein-protein interactions. The P domains of EspFU appear to direct localization
of the protein to sites of bacterial attachment, where they bind the SH3 domain of
IRTKS molecules clustered by Tir [125, 2]. IRTKS belongs to the I-BAR family of
membrane bending proteins; its zeppelin shaped homodimers aid in producing mem-
brane protrusions and may thereby contribute to architecture of EHEC pedestals
[80, 102, 29].
SH3 domains are an abundant and common motif for affecting cellular interac-
tions. Several cellular ligands have been shown to bind the SH3 domain of IRTKS
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and the high binding affinity of EspFU’s P domain ranks well among them [1]. The
IRTKS SH3 domain is unusual in that in it can accommodate two PxxP motifs (such
as that found in the P domain if EspFU) in its specificity binding pocket rather than
just one [103]. Some cellular ligands or potential ligands that also possess tandem
PxxP motifs include Esp8, Shank and BRAG [1].
The tandem PxxP binding regions of Eps8 and EspFU are nearly identical, sug-
gesting that EspFU may be mimicking Eps8 [2]. In support of a model where EspFU
must outcompete Eps8, the P domain of EspFU binds to the IRTKS SH3 domain
with much higher affinity due to the presence of a tryptophan between its two PxxP
motifs, rather than an alanine residue, which is found in the equivalent position in
between Eps8’s tandem PxxP motifs. Furthermore, swapping these two amino acids
between EspFU and Eps8 switches their relative binding affinities for the IRTKS
SH3 [2]. Thus, this EspFU ”tryptophan switch” may allow EHEC to usurp control
of IRTKS from Eps8.
Eps8 is a multifunction regulator of actin dynamics that integrates various sig-
naling pathways in the cell. It can act to induce disparate actin remodeling events
such as membrane ruﬄing and endocytosis by associating with different signaling
regulators and scaffolding proteins [39, 88, 123]. Its importance in regulating cellu-
lar structure and actin associated signaling is highlighted by studies linking Eps8 to
the motility and invasive potential of cancer cells as well as to the development of
microvilli and apical intestinal cells structure in animal models [49, 57, 119, 76]
Among its many partners, Eps8 that has been well documented to be the major
binding partner of IRSp53, an I-BAR protein closely related to IRTKS [49]. With
IRSp53, Eps8 participates in actin remodeling at membrane ruﬄes [40, 106]. IRTKS-
Eps8 interactions in vivo have been less well studied. However, its role in the proper
development and maintenance of apical structures [119] in intestinal cells makes
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Eps8 a potential target for bacterial effectors that are tasked with remodeling apical
cytoskeletal structures.
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4.3 Materials and Methods
4.3.1 Cell culture
Wildtype and Eps8-/- mouse embryonic fibroblasts (MEF), were cultured in
DMEM supplemented with 10% fetal bovine serum (FBS), penicillin-streptomycin,
and 2mM L-Glutamine. Cells were passed when confluent. For immunofluorescence
experiments, cells were washed with PBS, lifted with trypsin-EDTA, and seeded onto
#1.5, 12 mm coverslips in 24-well tissue culture plates at approxiately 50% conflu-
ence 12-18 hours before infection. For western blotting, cells were seeded into 6-well
tissue culture treated plates. HCT8 cells were cultured as described in section 3.3.1.
4.3.2 Transfection
MEFS were seeded at roughly 50% confluence onto #1.5 12mm coverslips 12 -
15 hours prior to transfection with 1-2 µg of mammalian expression plasmids using
Lipofectamine 2000 (Invitrogen #11668027) or FuGene (Promega #E2691) transfec-
tion reagents according to manufacturer’s instructions. Cell media was replaced with
Opti-MEM during transfection and replaced again with normal cell media 6 hours
after transfection.
4.3.3 Bacterial strains and plasmids
KC12, an EPEC strain that expresses EHEC Tir [21].was as the background strain
for infection studies in MEFS as EHEC strains induced too much cellular damage to
MEF cells before actin pedestal formation could be clearly observed. EspFU mutant
constructs in pDV48 were transformed into KC12 strains by electroporation. Refer
to tables C.1 and C.3 for strains plasmids.
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4.3.4 Infection
KC12 strains were cultured for transfection in the same manner as described in
section 3.3.4. For infection, bacteria were then resuspended in DMEM/2% FBS/20
mM HEPES/2mM glutamine to the following MOIs roughly 1:10. Infection was
carried out for 3 to 3.5 hours at 37°C with 5% CO2.
4.3.5 Immunoflourescence and imaging
Processing of infected samples for immunofluorenscence imaging was carried out
as described in section 3.3.6. Infected mouse embryonic fibroblasts were imaged
on an Olympus X70 or Ziess Axiovert 200M with the Ziess Apotome attachment.
Exposure times were set to capture 75% maximum intensity for postive samples for
each experiment. Z-sections were taken at 0.22 µm steps. HCT8 cells on transwells
were imaged on a Leica SP5 scanning confocal as described in section 3.3.6.
4.3.6 Co-immunoprecipitation (CO-IP)
For CO-IP experiments, HCT8 cells were seeded in 75 mm Transwell dishes (Corn-
ing #3420) at about 1.25 x 107 cells per dish and allowed to polarize for 5 days. After
3 days, half of the spent media was replaced with fresh media. Cells were infected
as described in section 3.3.4. with the following exceptions: Bacteria were resus-
pended in FAS media at an MOI of about 1:500. Cells were infected with 3 mL
of resuspended bacteria with 6 mL of FAS media in the outer well. Infection was
carried out for 6.5 to 7 hours. 2 mL of warm FAS media was added to the both the
inner transwells and the outer wells 3 hours after initiation of infection. After infec-
tion, CO-IP of infected whole cell lysates was performed using Thermo Scientific’s
Pierce Co-immunoprecipitation kit (# 26149) according to manufacturer’s instruc-
tions. 10 µg of anti-IRTKS or anti-IRSp53 antibody and 5 µg of anti-Eps8 antibody
was crosslinked per reaction. Protease inhibitors (Roche cOmplete mini EDTA-free
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protease inhibitor pill (Roche #04693159001) and 1 mM sodium orthovanodate) were
added the the IP/Lysis buffer prior to cell lysis. IP was conducted at 4°C for at least
15 hours.
4.3.7 Mithramycin treatment
HCT8 cells were polarized for 5 days as described in section 3.3.1. Mithramycin
(Santa Cruz #sc-200909) was stored as a 1 M stock in PBS at -20°C. Stock mithramycin
was diluted to working concentrations in cell culture media before use and handled
in the dark as much as possible. Media was removed from cells and replaced with
media with mithramycin for drug treatment. Treated cells were washed with HBSS
twice before experiments.
4.3.8 shRNA knockdown of Eps8 via lentivirus
Five shRNA sequences directed against Eps8 in the pLKO.1 lentiviral packing
vector were ordered from the UMass RNAi core (Gene ID #2059, Oligo ID #TRCN
00000 61543, TRCN 00000 61544, TRCN 00000 61545, TRCN 00000 61546, TRCN
00000 61547). shRNA plasmids and scramble control were transfected into 293T cells
along with psPAX2, expressing gag-pol, and pMD.2G, expressing VSV-G envelope
protein) using Mirus TransIT-293 Transfection reagent (Mirus #MIR 2704) in Opti-
MEM (Invitrogen #31985070). Viral supertants were collected from 293T cells at 24
hours and 48 hours after transfection, filtered through 45 µm mesh, and added with
8 µg per mL polybrene to subconfluent HCT8 cultures in two batches. Transduced
HCT8 cells were selected for stable knock down 48 hours after the last transduction
with 10 µg/mL puromycin through two passages.
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4.3.9 Western blots
Whole cell lysates were collected using Cytobuster (EMD Millipore #71009-3)
lysis buffer with Roche cOmplete mini-EDTA free protease inhibitor pill (Roche
#04693159001) according to manufacturer’s instructions. Subcellular fractions were
collected using ”Henrik’s protocol”. Briefly, cells were lysed in a triton extraction
buffer (1 % triton X-100, 100 mM sodium chloride, 10 mM HEPES, 2 mM EDTA, 4
mM sodium orthovanadate, 40 mM sodium fluoride) with gentle rocking at 4°C for
10 minutes. Cells were scraped from transwells or tissue culture vessels and lysates
were passed through a 25G needle three times and incubated on ice for 20 minutes
with occasional vortexing. After spinning at 14,000 rpm at 4°C for 30 minutes, the
supernatant was collected as the ”soluble fraction.” The pellet was then resuspended
in 1/5 volume SDS extraction buffer (triton extraction buffer with 1% SDS and 2
mM PMSF) and sonicated on ice for three rounds (5 seconds each round) at level 5
using a probe sonicator. After spinning at 14,000 rpm for 10 minutes at 4°C, this
supernatant was collected as the ”insoluble fraction.” Biorad’s DC or BCA protein
concentration assay kits were used to determine protein concentrations for lysate
samples against BSA standards. Samples were boiled in with laemmli buffer for 5 to
10 minutes before loading into precast SDS Tris-glycine polyacrylamide gels and run
at 120 to 180 V until desired separation of protein bands. Proteins were transferred
onto PVDF membranes by overnight wet transfer or onto nitrocellulose membranes
by semi-dry transfer. Membranes were blocked in 5% milk in PBST or TBST for
one hour at room temperature before incubation with primary antibody solutions in
5% milk in PBST or TBST overnight at 4°C with gentle rocking. After 3 washes in
PBST or TBST of at least 10 minutes each, membranes were incubated with HRP
conjugated secondary antibodies in 5% milk in PBST or TBST and incubated for
1 to 3 hours at room temperature with gentle rocking. Membranes were washed
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3 times prior to development with SuperSignal Pico West reagent (ThermoFisher).
Blots were imaged using the G:Box (Syngene) multi-purpose imager under automatic
exposure settings for each protein being probed.
88
4.4 Results
4.4.1 Pedestal incompetent EspFU constructs with mutations in the P
domain can form pedestals in the absence of Eps8
Eps8 knock out mouse embryonic fibroblast (MEF) cells, were initially used to
study the possible role of Eps8 as a competitor of EspFU for binding to IRTKS. Eps8
-/- cells grew more slowly than wildtype embryonic fibroblasts and appeared more
stretched and spiny, possibly reflecting important role of Eps8 in proliferation and
actin remodeling.
In order to study EHEC pedestal formation in MEF lines, KC12 was used as the
background strain instead of wildtype EHEC, which caused significant damage to
infected cells such that pedestal formation could not be easily assessed. KC12 is an
EPEC strain that has been engineered to make pedestals via EHEC pedestal path-
ways [21] by replacement of its tir allele with EHEC tir. Thus, KC12 alone cannot
generate pedestals unless complemented with pedestal competent EspFU constructs.
Upon infection, the absence of Eps8 permitted pedestal formation by constructs
of EspFU that are normally pedestal incompetent. HP*HP*HP* and HP*H*P*H*P
were both able to make robust pedestals in Eps8-/- cells that were indistinguish-
able from pedestals made by wildtype EspFU. Neither construct was able to make
pedestals in wildtype fibroblasts (figure 4.1).
Infection of Eps8 -/- cells by KC12 strains complemented with shorter pedestal
incompetent constructs of EspFU also resulted in some enhanced pedestal activity.
While recruitment of HP and HPH to sites of bacterial attachment was not very
strong in infected Eps8-/- cells, weak actin pedestals were associated at these sites.
No recruitment or recognizable actin pedestals were seen in wildtype cells infected
with KC12 complemented with HP or HPH (figure 4.2).
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Figure 4.1: Pedestal incompetent mutants can form pedestals in the
absence of Eps8.
Wildtype or Eps8 -/- cells MEFS infected with KC12 complemented
with HP*HP*HP* or HP*H*P*H*P were stained for bacteria (blue),
the myc-tagged EspFU construct (red), and actin (green).
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Figure 4.1: Pedestal incompetent mutants can form pedestals in the absence of Eps8.
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Figure 4.2: One P domain can generate weak actin pedestals in the
absence of Eps8.
Wildtype or Eps8 -/- cells MEFS infected with KC12 complemented
with HP or HPH were stained for bacteria (blue), the myc-tagged
EspFU construct (red), IRTKS (yellow) and actin (green).
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Figure 4.2: One P domain can generate weak actin pedestals in the absence of Eps8.
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4.4.2 Ectopic expression of Eps8 decreases pedestal formation activity
by pedestal competent EspFU mutants in MEF cells
Transfection of a plasmid expressing wildtype mouse GFP-Eps8 into Eps8-/-
MEF cells prevented pedestal formation by HP*HP*HP*, thus restoring the wildtype
MEF EspFU requirement phenotype. When ectopic GFP-Eps8 was expressed in
wildtype MEF cells, HPHPHP was able to make pedestals less efficiently, suggesting
that Eps8 overexpression can compete against pedestal competent EspFU constructs.
Ectopically expressed GFP-Eps8 could be localized to sites of bacteria attachment
by immunofluorescence with anti-GFP antibody (figure 4.3).
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Figure 4.3: Ectopic expression of Eps8 decreases pedestal activity.
Wildtype and MEFS overexpressing Eps8-GFP or GFP alone and in-
fected with KC12 complemented with HPHPHP were stained for bac-
teria (blue), the myc-tagged EspFU construct (red), IRTKS or GFP-
tagged Eps8 (yellow) and actin (green).
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Figure 4.3: Ectopic expression of Eps8 decreases pedestal activity.
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4.4.3 Eps8 is localized to apical membrane surfaces in polarized HCT8
cells
Eps8 appears highly abundant in polarized HCT8 cells. Total Eps8 levels were
not significantly different between subconfluent, confluent and polarized HCT8 cells
when lysates were adjusted for total protein concentration, while total IRTKS levels
increased in confluent and polarized HCT8 cells (figure 4.4). Interestingly, GADPH
levels appear to decrease when HCT8 cells were confluent or polarized. Eps8 was
found to be mostly membrane associated (in insoluble fraction) while IRTKS was
distributed in both the soluble and insoluble fractions in roughly equal amounts
(figure 4.6). Exact concentrations of Eps8 in cell lysates could not be determined
because a recombinant protein was not available.
On immunofluorescence, Eps8 appeared to be concentrated at the apical surface
of polarized HCT8 monolayers. Figure 4.5 shows single apical Z-slices of uninfected
and infected cell monolayers and corresponding X-Z and Y-Z projections. In in-
fected polarized cells, the apical localization of Eps8 did not appear to change. No
Eps8 foci were apparent when polarized HCT8 cells were infected with EHEC ∆dam
∆espFU strains complemented with pedestal incompetent EspFU constructs. Cell
monolayers infected with pedestal competent mutants also did not show enhanced
Eps8 localization around attached bacteria that were not making pedestals. Mem-
brane associated Eps8 in subcellular fractions appeared to increase slightly after
infection with pedestal competent strains (figure 4.6) on western blot. However, fig-
ure 4.6 represents a preliminary pilot experiment and requires repetition and pedestal
incompetent infection controls.
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Figure 4.4: Eps8 is abundant in HCT8 cells; protein levels do not
change in with polarization.
Whole cell HCT8 lysates of two subconfluent, one confluent, and one
polarized culture were probed for Eps8, IRTKS, Tubulin and GAPDH.
Protein loading was normalized to 20 µg in each lane.
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Figure 4.4: Eps8 is abundant in HCT8 cells; protein levels do not change in with
polarization.
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Figure 4.5: Eps8 is concentrated at the apical surface in polarized HCT8
cells.
Polarized HCT8 cells infected with various EHEC ∆dam ∆espFU
strains were stained for bacteria (blue), Eps8 (magenta) and actin
(green). Images of X-Y planes (largest square panel in each image)
are single Z slices taken at apical planes. X-Z and Y-Z projections
above and to the left of X-Y planes represent projections at crosshairs
in the X-Y planes. Arrowheads point to apical surface of cells in X-Z
and Y-Z projections.
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Figure 4.5: Eps8 is concentrated at the apical surface in polarized HCT8 cells.
101
Figure 4.6: Infection with pedestal competent strains of EspFU may
affect the relative subcellular localization of Eps8.
Fractionated lysates of uninfected polarized HCT8 or polarized HCT8
infected with pedestal competent EHEC strains were probed for mem-
brane associated and cytosolic Eps8 and IRTKS.
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Figure 4.6: Infection with pedestal competent strains of EspFU may affect the relative
subcellular localization of Eps8.
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4.4.4 Co-immunoprecipitation (CO-IP) of IRTKS with Eps8 cells sug-
gests competition between EspFU and Eps8 in polarized HCT8
cells
If the requirement for multiple P domains of EspFU for actin pedestal formation
in polarized HCT8 cells is also due to competition against Eps8 for the same binding
site of IRTKS, then recruitment of IRTKS by EspFU might displace any Eps8 that is
already bound to IRTKS. Co-immunoprecipitation of infected cell lysates for either
IRTKS or Eps8 should thus show a change in levels of IRTKS bound to Eps8 upon
infection of HCT8 cells with pedestal competent EspFU constructs.
Crosslinking of anti-IRTKS antibody to CO-IP beads was able to capture nearly
all IRTKS from uninfected and infected whole cell lysates of polarized HCT8 cells.
However, Eps8 was not detected in the CO-IP eluate (figure 4.7). Likewise, crosslink-
ing of anti-IRSp53 antibody to did not capture Eps8 even though IRSp53 is reported
to be the major binding partner of Eps8 (data not shown).
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Figure 4.7: Eps8 is not captured by CO-IP with IRTKS.
Uninfected and infected polarized HCT8 whole cell lysates were im-
munoprecipitated (IP) with anti-IRTKS antibody. Pre-IP lysates, IP,
and flow through from IP were probed for Eps8 and IRTKS. Pre-IP
lysates were also probed for GAPDH as loading control. Lanes are 1.
Uninfected, 2. Infected with EHEC ∆dam ∆espFU, 3. Infected with
EHEC ∆dam ∆espFU complemented with full length EspFU, 4. In-
fected with EHEC ∆dam ∆espFU complemented with HPHPHP, and 5.
Infected with EHEC ∆dam ∆espFU complemented with HP*HP*HP*.
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Figure 4.7: Eps8 is not captured by CO-IP with IRTKS.
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Crosslinking of anti-Eps8 antibody to CO-IP beads on the other hand was able to
capture both IRTKS and IRSp53 by CO-IP. Only a fraction of total cellular IRTKS is
bound to Eps8. IRSp53, normally undetectable in HCT8 whole cell lysates, becomes
enriched and easily detected by CO-IP with Eps8 (figure 4.8). The level of IRSp53
enrichment and detection after IP is curious given that volume-wise, the IP eluate
is only 3.33 times as concentrated as the input lysate. Both IRTKS and IRSp53
show an apparent 5 to 6 kDa reduction in size when captured by CO-IP with Eps8,
suggesting a possible modification after Eps8 binding.
No Eps8 or IRTKS bands were detected in control CO-IP’s using non-specific
mouse IgG’s crosslinked to protein G beads (figure 4.9), indicting that the above
bands seen on CO-IP are specific. The IRTKS antibody used detects recombinant
IRTKS specifically over recombinant IRSp53 and gives a clean band on western blot
of cellular lysates at the predicted molecular size (data not shown).
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Figure 4.8: IRTKS and IRSp53 are captured by CO-IP with Eps8
Uninfected polarized HCT8 whole cell lysates were immunoprecipi-
tated (IP) with anti-Eps8 antibody. Pre-IP lysates (Ly), pre-IP lysates
cleared through agarose beads (CL), IP, and flow through from IP (FT)
were probed for Eps8 and IRTKS. L stands for molecular weight ladder.
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Figure 4.8: IRTKS and IRSp53 are captured by CO-IP with Eps8
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Polarized HCT8 cells infected with pedestal competent strains delivering HPH-
PHP or full-length EspFU, showed decreased levels of IRTKS bound to Eps8 com-
pared to cells infected with EHEC ∆dam ∆espFU or EHEC ∆dam ∆espFU comple-
mented with the pedestal incompetent PHP construct. More IRTKS was bound to
Eps8 in cells infected with EHEC ∆dam ∆espFU complemented with the pedestal
incompetent HP*HP*HP* construct compared to its pedestal competent counter-
part, HPHPHP, indicating that HP*HP*HP* was less able to compete against Eps8
for IRTKS binding (figure 4.9). Figure 4.9 represents a preliminary experiment that
needs to be repeated for final conclusions.
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Figure 4.9: Pedestal competent EspFU constructs decrease IRTKS
bound to Eps8.
Whole cell lysates from uninfected polarized HCT8 (1) and polar-
ized HCT8 infected with EHEC ∆dam ∆espFU(2) and EHEC ∆dam
∆espFU complemented with PHP (3), HPHPHP (4), HP*HP*HP*(5),
and full length EspFU(5) were immunoprecipitated (IP) with anti-Eps8
antibody (A) and probed for Eps8 and IRTKS. Control western blots
(B) of input lysates, flow through from IP with anti-Eps8 antibody,
and control IP with non-specific IgG were probed for Eps8, IRTKS,
and GAPDH.
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Figure 4.9: Pedestal competent EspFU constructs decrease IRTKS bound to Eps8.
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4.4.5 Mithramycin treatment reduces Eps8 but does not permit pedestal
formation by pedestal incompetent EspFU constructs
Mithramycin, a DNA and RNA polymerase inhibitor has been reported to de-
crease Eps8 mRNA and protein levels in a dose dependent manner [135] and has
been used to study phenotypes of cancer cell lines that involve Eps8 [135, 57].
Mithramycin treatment of polarized HCT8 cells decreased Eps8 protein in a dose
dependent manner, with no obvious gross changes in the polarized monolayer up to
5 µM. Treatment for 24 hours at 5 µM resulted in roughly the same level of Eps8
decrease as treatment for 42 hours (figure 4.10).
Treatment of polarized HCT8 cells for 24 hours with doses up to 50 µM Mithramycin
was not sufficient, however, to allow for pedestal formation of any EspFU mutant with
a W33A mutation in any P domain (figure 4.11).
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Figure 4.10: Mithramycin decreased Eps8 in polarized HCT8 cells.
Fractionated subcellular lysates of untreated polarized HCT8 cells or
polarized HCT8 cells treated for 24 or 42 hours with 3 concentrations
of Mithramycin were probed for Eps8.
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Figure 4.10: Mithramycin decreased Eps8 in polarized HCT8 cells.
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Figure 4.11: Mithramycin treatment of polarized HCT8 cells did not
permit pedestal formation by pedestal incompetent EspFU mutants
with W33A mutation.
Polarized HCT8 cells treated with various doses of mithramycin and
infected with pedestal incompetent EspFU mutants were stained for
bacteria (blue), myc-tagged EspFU construct (red) and actin (green).
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Figure 4.11: Mithramycin treatment of polarized HCT8 cells did not permit pedestal
formation by pedestal incompetent EspFU mutants with W33A mutation.
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4.4.6 shRNA knock down of Eps8 in HCT8 cells does not permit pedestal
formation by a pedestal incompetent EspFU construct
During selection under 10 µg/mL puromycin treatment, 4 out of 5 HCT8 lines
transduced with shRNA against Eps8 showed significantly delayed growth and changes
in cellular morphology compared to untransduced HCT8 cells or HCT8 cells trans-
duced with scramble shRNA. These four lines recovered to nearly widetype growth
levels after two weeks, but did not recover wildtype morphology (figure 4.12).
Only one knock down line (#4) showed significant reduction on Esp8 levels which
was also accompanied by a decrease in IRTKS as detected in unfractionated whole
cell lysate (figure 4.13). When seeded at subconflence, no lines tested permitted
pedestal formation even at subconfluence when infected with EHEC ∆dam ∆espFU
complemented with H*PH*PH*P. In contrast, subconfluent wildtype HCT8 cells
infected with EHEC ∆dam ∆espFU complemented with HPHPHP or full length
EspFU result in robust actin pedestals that are easily apparent (figure 4.14).
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Figure 4.12: shRNA knock of Eps8 in HCT8 cells results in altered
morphology.
Untransduced HCT8 cells and HCT8 cells transduced with scramble
shRNA or shRNAs targetting Eps8 (lines #3 through 7) were imaged
under widefield with phase contrast.
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Figure 4.12: shRNA knock of Eps8 in HCT8 cells results in altered morphology.
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Figure 4.13: shRNA knock of Eps8 in HCT8 cells
Whole cells lysates of untransduced HCT8 or HCT8 lines transduced
with scramble or shRNAs targeting Eps8 were probed for Esp8 and
IRTKS.
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Figure 4.13: shRNA knock of Eps8 in HCT8 cells
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Figure 4.14: HCT8 cell lines knocked down for Eps8 did not permit
pedestal formation by the pedestal incompetent mutant HP*HP*HP*.
Subconfluent wildtype HCT8 cells infected with EHEC ∆dam ∆espFU
complemented with HPHPHP or full length EspFU and subconfluent
HCT8 lines transduced with shRNA’s targeting Eps8 (#3 through 7)
infected with EHEC ∆dam ∆espFU complemented with HP*HP*HP*
were stained for bacteria (blue), myc-tagged EspFU construct (red),
and phalloidin (green).
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Figure 4.14: HCT8 cell lines knocked down for Eps8 did not permit pedestal forma-
tion by the pedestal incompetent mutant HP*HP*HP*.
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4.5 Conclusion
Although the tryptophan substitution in between the double PxxP motifs of
EspFU’s P domain should give EspFU an advantage over Eps8 in binding IRTKS
[2], multiple P domains are nonetheless required for proper recruitment of EspFU
to sites of bacterial attachment. Polarization additionally increases the minimum
number of P domains required. This suggests that despite the advantage afforded
by the tryptophan switch, EspFU needs additional strategies to hijack IRTKS and
achieves this perhaps by avidity.
When Eps8 is completely absent from cells, pedestal incompetent mutants with
W33A mutations in a three repeat construct are able to form pedestals as robustly
as HPHPHP or full length EspFU. Despite lack of competition from Eps8 however,
constructs with less than the minimum number of P’s required for pedestal formation
(two P’s for MEFS) still struggle to initiate actin assembly beneath attached bacteria.
Clustering and recruitment of the constructs HP and HPH underneath bacteria are
much less apparent and actin pedestals appear smaller and less robust. This suggest
the presence of other intracellular pressures on EspFU that make multiple functional
repeats advantageous, an observation also seen in vitro [104].
Differences in the amount of IRTKS coimmunoprecipitated with Eps8 after infec-
tion supports a competition model between Eps8 and EspFU for binding to IRTKS.
In preliminary experiments, pedestal incompetent mutants of EspFU were not as
able to displace IRTKS from Eps8, while pedestal competent mutants clearly de-
creased IRTKS captured with Eps8. Although not all intracellular IRTKS appears
to be associated with Eps8, IRTKS complexed to Eps8 at the apical membrane could
provide an accessible pool of IRTKS from which both Tir and EspFU can recruit to
meet at sites of bacterial attachment. The apical localization of Eps8 in polarized
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HCT8 may also provide local concentrations of IRTKS in close proximity to sites of
bacterial attachment.
Eps8 appears to be just as abundant in subconfluent HCT8 cells as it is in conflu-
ent and polarized HCT8 cells. The increased requirement requirement for the num-
ber of EspFU domains needed for actin pedestal formation in confluent and polarized
HCT8 may reflect changes in the cellular architecture, subcellular protein organiza-
tion, or regulatory mechanisms upon polarization that pose challenges to unsurpers
of actin signaling pathways. A simple hypothesis is that the relative abundance of
Eps8 compared to EspFU at the apical membrane may be increased polarized cells.
Attempts to reduce Eps8 levels in HCT8 cells did not allow for actin pedestal
formation by any EspFU constructs bearing W33A mutations. Mithramycin treat-
ment of already polarized monolayers reduced Eps8 levels, but perhaps not enough to
see an effect. These experiments are preliminary and conducted with at limited set
mutants. A more through analysis through treatment and infection of non-polarized
HCT8 cells with mutants that display partial activity may provide more conclusive
data. Since mithramycin treatment only partially reduces Eps8 levels, its effects on
actin pedestal formation by the various EspFU mutants might be more pronounced
under conditions and with mutants that show partial pedestal activity.
shRNA knockdown of Eps8 resulted in severe growth defects and obvious changes
in cellular morphology (except in shRNA line #6) that highlight the important role
of Eps8 for normal cellular architecture and growth. The only shRNA line (line #4)
that showed a significant knockdown of Eps8 by western blot also did not permit
pedestal formation by EspFU with W33A mutations in the P domains. It may be that
even minuscule amounts of Eps8 can prevent these weaker mutants from successfully
binding IRTKS. We suspect that the amount of EspFU injected into host cells may be
minute compared to host proteins, especially considering the number of bacteria that
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can be found on per cell on infected polarized monolayers, (usually less than ten if
present). And both injected Tir as well as EspFU are beyond Western blot detection
limits in infected cell lysates (data not shown). Thus, perhaps even a significant
knock down in Eps8 protein levels is not permissible for actin pedestal formation by
W33A mutants, as it is in Eps8 knock out MEFs.
The infection results for Eps8 knock down line #4 could also indicate that Eps8
may not in fact be a direct competitor for EspFU or that there may be other redun-
dant host proteins in HCT8 cells not present in MEF. Yet another possible explana-
tion is that the Eps8 in line #4 mutated under selective pressure during puromycin
treatment and the mutation affected recognition by the monoclonal antibody used
to detect the protein. The growth pattern of this line supports this theory some-
what. Except for line #6, which showed no reduction in Eps8 levels on western blot,
all of the other shRNA lines were very slow to grow initially and displayed severe
morphological disturbances. for about two weeks after the start of selection under
puromycin. Growth rate was minimal, but suddenly increased to near wildtype levels
overnight from less than 10 % confluence, suggesting that the cells had adapted to
the selective pressure. As with the CO-IP and mithramycin experiments, the shRNA
studies are preliminary. The Eps8 knock down cells lines should be further charac-
terized and experiments should be repeated for more conclusive interpretations.
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CHAPTER 5
DISCUSSION
5.1 Challenges to establishing infection
EHEC faces many challenges in establishing an infective niche in human hosts.
In the course of evolving towards its natural life cycle of inhabiting the gastrointesti-
nal tract of ruminants, shedding into the environment (perhaps on grassy pastures?)
and re-ingestion, EHEC may have evolved many traits that also enable it to cause
human outbreaks in developed countries today. For example, EHEC must survive
refrigeration, sometimes freezing, and conventional processed meat and produce san-
itation protocols. Traits that help it survive in the open environment after shedding
from animals likely help with survival in food processing facitlies and grocery store
environments as well. More recently, specific factors that allow EHEC to bind leafy
greens have even been found [7] for example.
Once ingested by unsuspecting humans, EHEC must overcome multiple chal-
lenges in the gut environment (For a detailed review, see [46]). EHEC survives the
highly acidic environment of the stomach with such success that the infectious dose
in humans is thought to be as low as 50-100 bacteria. A number of acid tolerance
mechanisms are thought to aid EHEC survival [46]. In the colon, EHEC is able to
establish a presence in spite of resident microbiota and a protective mucus layer.
In addition, AE lesions made by EHEC and EPEC provide these pathogens with a
unique and effective strategy of intimate attachment.
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To make AE lesions, EHEC must induce a dramatic reorganization of cytoskele-
tal structures, beginning with the effacement of microvilli. Highly organized, yet
dynamic [12, 43], microvillar structure must be under constant regulation. Pathogen
induced calpain activation has now been shown to be involved in microvilli effacement
by three gut pathogens, EPEC, EHEC, and H. pylori [69, 127]. Through the cleavage
of Ezrin, a calpain substrate responsible for anchoring cytoskeletal components to
the plasma membrane, these pathogens are able to disrupt a key cellular interaction
that leads so instability of the microvillus structure. In the case of H. pylori, the ef-
fector VacA was identified to initiate these effects [127]. While bacterial components
responsible for calpain activation are not currently known for EHEC and EPEC,
unpublished evidence from our lab and the Herman lab (Tufts Univesity) point to
evidence for T3SS effectors. In manipulating calpain activity, these pathogens have
succeeded in disrupting a central regulator of cytoskeletal dynamics, which may also
have wider impacts on cellular physiology during infection.
5.2 EspFU repeats increase functional affinity
The second piece to AE lesion formation is the formation of actin pedestals.
While pathogen induced actin assembly is not uncommon, the rebuilding of actin
structures by an extracellular pathogen in a directed and organized manner is quite
remarkable in the midst of tight cellular regulation. Tir is a rather clever invention in
this respect. By being both an extracellular anchoring site for bacterial attachment,
and an intracellular signaling molecule, Tir is able to direct location specific actin
assembly [132, 70] underneath sites of bacterial attachment. And through recruit-
ment of key adaptor molecules, Tir is able to usurp control of by N-WASP, which is
normally kept inactive and under tight regulation [111, 79].
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EPEC and EHEC both hijack N-WASP by Tir initiated signaling cascades, but
EHEC has evolved to include another T3SS effector in concert with Tir. It is unclear
what advantages EHEC may have in using EspFU in its pedestal formation pathway.
EspFU takes control of key host proteins by molecular mimicry and multivalency
through repeating functional units, strategies that are also commonly seem with
other T3SS effectors [50], including plant T3SS effectors [134, 8]. Most of the bulk
of EspFU functions in actin pedestal formation and consists of repeating H and
P domains, which can be truly be considered as two separate functional entities.
The H domains are ultimately responsible for hijacking the actin assembly pathway
through activation of N-WASP and the P domains direct localization of EspFU to
sites of bacterial attachment via binding to Tir. These modular entities can even
be exchanged. The related effector, EspF, which also consists of repeating H and P
domains, can be made to behave like EspFU by exchanging its native P domain that
directs it to SNX9, with that of EspFU (unpublished data by Didier Vingadassalom).
Though both the H and P domains can bind their respective targets with higher
affinity than native host binding partners [1, 26], the presence of multiple repeats in
nature points to additional challenges in the cell that enhanced affinity alone cannot
overcome.
Sallee and coworkers have investigated the degree of actin assembly activity
gained by additional EspFU repeats in vitro [104] and observed kinetics that also
match well with the number of EspFU repeats surveyed in nature [54]. In their sys-
tem, one EspFU repeat showed miminal N-WASP activation. Adding an additional
repeat more than doubled N-WASP activity and a third repeat nearly tripled activ-
ity. The degree of gains with the fourth, fifth and sixth repeats were much less with
maximal activity peaking at six repeats [104]. In Garmendia’s 2005 survey, 99% of
EspFU alleles encoded three or more repeats, with a vast majority (79%) encoding
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six repeats. Alleles with more than six repeats were found in less than 1% of strains
surveyed[54].
While Sallee’s study was in vitro, the results also correlate interestingly with
observations in our infection model. Upon HCT8 cell polarization, the minimal
number of EspU repeats need for actin pedestals increases to three repeats, with a
particular need for three P domains. This need for additional functional P domains
suggests that additional structural challenges may be hindering EspFU localization
after cells undergo polarization. In addition to considering the presence of additional
host proteins that may interfere with EspFU localization, relative concentrations and
locations of host and bacterial components are also factors to consider.
EspFU may have evolved to overcome challenges to hijacking host proteins in
polarized cells by increasing its overall functional effectiveness through repetition of
its functional units. The need specifically for additional P domains over H domains
in actin pedestal formation in polarized HCT8 cells indicate that the challenges
lie more against the targeting module of EspFU. Repeating P domains may help
”supercharge” this homing/targeting module through increasing avidity, resulting
increasing overall functional activity of the P domains in a single EspFU molecule.
In a more crowded subcellular environment or in an intracellular environment
where EspFU becomes less likely to bind IRTKS for example, increasing the func-
tional activity of this targeting module via multiple repeats may increase the chances
that EspFU actually encounters and binds IRTKS. As well, ”supercharging” the tar-
geting module may also increase its functional activity (in binding to IRTKS) in
an environment that may be hostile to perturbations of native host protein-protein
interactions. As protein-protein interactions are dynamic, concentrating functional
domains via repeats may increase the likelihood of dislodging and displacing native
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host protein-protein interactions by increasing the local concentration of the ”com-
peting” interaction.
Increased functional activity may also help stabilize EspFU to critical protein
complexes underneath sites of bacterial attachment. Immunofluorescence staining
shows that Tir and IRTKS can localize underneath sites of bacterial independently
of EspFU and both of these EHEC pedestal components are observed at early time
points of infection when no actin assemble occurs yet (data not shown). Both Tir
and IRTKS form homo-dimers, as well as intimin on the outer surface of EHEC. It
is reasonable to imagine that intimin, Tir, and IRTKS, through association of homo-
dimers at multiple levels, form macromolecular complexes concentrated underneath
intimately bound EHEC.
A single EspFU molecular that is ”supercharged” for the targeting module may
more stably interact with and bind the Tir/IRTKS complex. In a repeating struc-
tural arrangement, the binding of a single P domain may bring the next P domain
within optimal close proximity to lead to cooperative binding of the next P do-
main and so forth. Thus, the overall affinity of EspFU to the Tir/IRTKS complex
is enhanced by increasing avidity of the targeting module. And three or more P
domains, in particular, may add more to the degree of macromolecular complexing,
compared to just two P domains. While an EspFU with two P’s has the potential
to bind two SH3’s of IRTKS, the SH3’s could be from the same IRTKS dimer. In
this case, multimerization at this level is not enhanced. With three or more P do-
mains, one EspFU molecule must bind two or more IRTKS dimers, thus enhancing
macromolecular complexing of actin pedestal initiating factors underneath sites of
bacterial attachment.
For actin pedestal formation, recruitment of EspFU to the IRTKS/Tir complex
via P domains may be thought of as a critical juncture in recruiting host actin as-
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sembly machinery to sites of bacterial attachment. And increased functional activity
achieved by increasing the avidity of P domain and IRTKS interactions may help
overcome intracellular challenges that require more P domains for actin pedestal
formation in polarized intestinal cell.
5.3 Eps8 and EspFU competition for IRTKS
Considering the abundance and ubiquity of SH3 domains and SH3 ligands in
mammalian cells, it is not unreasonable to speculate that EspFU’s P domains may
need to outcompete natural host ligands for accessing the SH3 domains of IRTKS
dimers. The host protein Eps8 has emerged as likely competitor against which
EspFU’s P domains have evolved to outcompete. While the total relative amount of
Eps8 does not change, Eps8 may be more concentrated and organized at the apical
surface in a polarized intestinal monolayer. Indeed, Eps8 can be found apically, but
its position there in relation to its role in EHEC pedestal formation requires further
study.
It is tempting to think that Eps8 might provide a readily accessible concentration
of IRTKS at the apical membrane that could be used both by Tir and EspFU. Since
Tir binds IRTKS in the IMD region, there is no need to dislodge Eps8 from IRTKS.
EspFU may then subsequently bind to the Tir/IRTKS complex by dislodging Eps8.
This hypothesis is not well supported by our preliminary imaging data. IRTKS
can be easily seen at sites of bacterial attachment by immunoflourescence, while
Esp8 is rarely found concentrated underneath bacteria. Eps8 is sometimes seen
in pedestals, but not always and never in cells infected with pedestal incompetent
constructs of EspFU. This implies that IRTKS bound to Tir do not carry Eps8,
against which EspFU can exchange positions. However, a separate population of
IRTKS concentrated at the apical membrane by Eps8 may still aid in directing EspFU
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closer to Tir. Separate local concentrations of Eps8-IRTKS-EspFU complexes at the
apical membrane may exist alongside Tir-IRTKS complexes at the apical membrane.
Subsequent recruitment of EspFU to the Tir/IRTKS complex could pontentially be
achieved by dimer exchange of IRTKS molecules in close proximity.
5.4 Final thoughts
Additional questions remain about the activities of EspFU after injection into
host cells. How EspFU finds its way to the Tir/IRTKS complex and its path after
injection through the T3SS is still unclear. When ectopically expressed in cultured
cells, EspFU can be found localized very clearly to mitochondria without noticeably
perturbing intracellular actin organization (unpublished data by Alenka Lovy, Tufts
University) or mitochondrial dynamics. Is actin assembly activity of the H domains
dependent on clustering EspFU at the membrane or perhaps the presence of other
bacterial factors? EspFU has also been shown to complement EspF activity in EPEC,
where it is not needed for actin pedestal formation [126]. Could EspFU have other
functions that are redundant with EspF, which differs from EspFU in the P domains,
thereby targeting it to a different cellular target?
Disruption of the host cell architecture not only alters the physical structure of the
cell, but most certainly upsets normal cell physiology in a manner that contributes
to diarrhea. Apical surface of intestinal cells is adapted for nutrient absorption and
effacement of microvilli alone should cause displacement of aquaporins and other api-
cal nutrient transporters. In addition to the activation of calpain and the dramatic
rearrangement of the cytoskeleton associated with AE lesion formation, the coordi-
nated activities of other T3SS effectors all together disrupt intestinal cell function
and not doubt contribute to EHEC’s hallmark symptom of bloody diarrhea.
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APPENDIX A
A POTENTIAL STRATEGY FOR STUDYING T3SS
EFFECTOR FUNCTION USING APEX FUSION
PROTEINS
A.1 Acknowledegments
Plasmids encoding optimized APEX enzymes were generated by the lab of Alice
Ting (MIT) and biotin-phenol substrate made by Aditya Bandekar (Sassetti Lab,
UMMS).
A.2 Introduction
Knowing the exact intracellular locations and binding partners of bacterial effec-
tors would be a huge advantage in studying effector function. Effector mechanisms
are often deduced indirectly. In vitro studies are limited to the components of the
in vitro system. And while effector deletions and complementation with effector
mutants can provide useful information about critical functional components of the
effector itself, such techniques with mammalian cell factors can cause gross defects
in the cell (as demonstrated in figure 4.12) or yield phenotypes driven by off target
effects.
Recently, a strategy to specifically label proteins by TEM or label proteins in
close proximity was developed by the Ting lab [78, 97]. The method involves fusing
an optimized plant peroxidase to a protein of interest. In TEM, samples containing
the fusion peroxidase can be highlighted and specifically stained for with an EM
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compatible substrate for the peroxidase. This staining method offers better labeling
than conventional techniques. In live cells, treatment with another peroxidase sub-
strate, biotin-phenol, allows the fusion construct to tag nearby proteins with biotin.
Proteomic mass spec analysis of cell lysates with fusion-APEX would yield informa-
tion about potential binding partners, proteins in complexes, transient interactions,
and intracellular localization.
In this study, APEX was cloned as a fusion protein with EspFU to determine its
utility in studying T3SS effectors in infection models.
A.3 Materials and Methods
A.3.1 Cloning EspFU-APEX fusion and bacterial strains
Bacterial complementation plasmids expressing EspFU and HPHPHP fused to soy
or pea APEX were generated by overlap extension PCR according to [13]. Primers
used are listed in table C.2. Constructed plasmids encoding EspFU or HPHPHP
fused to soy or pea APEX enzymes were used to complement EHEC ∆dam ∆espFU
(Table C.1).
A.3.2 Cell culture and infection
HCT8 cells were cultured and polarized as described in section 3.3.1. Infection
was carried out as described in section 3.3.4.
A.3.3 Intracellular biotin labeling
Cells were supplemented with 7µM HEME in regular cell culture for 24 hours
prior to infection. Heme was not included in media during infection. After infection,
cells were treated for 30 minutes with biotin-phenol labeling substrate (a generous gift
from Aditya Bandekar and Chris Sassetti). Labeling reaction was catalyzed by addi-
tion of hydrogen peroxide (final concentration of 1mM)for one minute. The reaction
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was stopped by adding ”quencher solution” (10 mM sodium azide, 10 mM sodium
ascorbate, 5 mM Trolox final concentrations) in cell media. Cells were washed in
PBS with quencher solution prior to immunofluorescent staining or lysate collection.
A.3.4 Imaging
Cells were processed for immunofluorescent imaging as described in section 3.3.6
and imaged on a Leica SP5 confocal microscope.
A.3.5 Western blot
Whole cell lysates from infected polarized HCT8 treated for APEX biotin label-
ing were collected as described in section 4.3.9. Lysates were prepared for western
blotting as described in section 4.3.9. and probed with streptavidin-HRP.
A.4 Results
A.4.1 EspFU-APEX fusions retain normal T3SS effector function
EspFU and HPHPHP-APEX fusions were able to be translocated through the
T3SS and function normally in actin pedestal formation. Actin pedestals were clearly
discernable by immunofluorescence in polarized HCT8 cells infected with EHEC
∆dam ∆espFU complemented with EspFU or HPHPHP fusion APEX constructs
(Figure A.1).
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Figure A.1: APEX fusions are translocated and do not intefere with
effector function
Polarized HCT8 cells infected with EHEC ∆dam ∆espFU comple-
mented with EspFU or HPHPHP -APEX fusions were stained for bac-
teria (blue), Tir (red) and actin (green).
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Figure A.1: APEX fusions are translocated and do not intefere with effector function
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A.4.2 APEX biotin labeling
Biotin-phenol treatment of HCT8 cells resulted in a general increase in biotiny-
lated proteins, even in HCT8 cells infected with EHEC not delivering APEX. This
maybe due to endogenous enzyme activity by either cellular or bacterial T3SS deliv-
ered enzymes. However, lysates from HCT8 cells infected with EHEC ∆dam ∆espFU
strains compemented with EspFU-soy or pea APEX showed slightly more biotinyla-
tion overall and additional biotinylated bands in soluble fractions.
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Figure A.2: APEX Biotin labeling
Lysates of polarized HCT8 cells infected with EHEC ∆dam ∆espFU
complemented with EspFU or HPHPHP -APEX fusions were probed
for biotinylated proteins.
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Figure A.2: APEX Biotin labeling
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A.5 Conclusions
APEX fusions of bacterial effector proteins could be used as an effective tool in
studying the function of known and unknown T3SS effectors. Because APEX can be
translocated by the T3SS, effector-APEX fusions could be used in infection models
and studied at physiologically relevant concentrations and in correct intracellular
compartments.
TEM studies using effector-APEX fusions would provide specific data on effector
localization and eliminates the need for TEM compatible antibodies. While data
from mass spec will be potentially noisy, APEX labeling could help identify pre-
viously unknown protein-protein interactions between bacterial effectors and host
proteins as well as between effectors.
A.6 Project Proposal
The utility of using APEX fusions in the study of T3SS effectors could be shown
by studying APEX fused to effectors for which effector and host protein interactions
have been well characterized. This proposal outlines such experiments using EspFU-
APEX fusions as a proof of principle.
A.6.1 Aim 1: Demonstrate that APEX can be used to study T3SS ef-
fectors
A.6.1.1 EspFU-APEX fusions function after secretion through the T3SS.
Figure A.1 shows that EspFU-APEX fusions can be secreted through the T3SS
into infected host cells without affecting the function of EspFU. APEX activity
should also be assessed after T3SS secretion. EHEC strains complemented with
EspFU-APEX can be treated with congo red as described in section 3.3.5 to induce
secretion of the fusion protein into the media. Supernatants can then be tested for
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APEX activity by assaying for reduction of nitroblue tetrazolium in native gel as
described in [81].
A.6.1.2 EspFU-APEX labels known binding partners.
Proteomic mass spec analysis of cell lysates infected with EHEC strains delivering
EspFU-APEX under conditions that produce actin pedestals should show that N-
WASP and IRTKS are biotinylated by APEX. Tir and Arp2/3 may also be labeled
if they are within close enough proximity. Labeling of other host proteins that
have also been reported to localized to actin pedestals, but not involved in pedestal
formation process, may result in noise in the proteomic analysis, but nonetheless
would also help confirm the proximity labeling activity of APEX.
A.6.2 Aim 2: Demonstrate that APEX can provide new information on
known interactions
Interactions of EspFU with its host binding partners (N-WASP and IRTKS) have
been well characterized in vitro and in infected cells. However, specific questions
about these interactions during the time course of infection remain unanswered.
A.6.2.1 Which comes first, N-WASP or IRTKS?
Proteomic mass spec analysis of cell lysates infected with EHEC strains delivering
EspFU-APEX at different time points of infection may show differences in the degree
of N-WASP and IRTKS labeling by APEX. If one protein is preferentially labeled
over the other at earlier time points, then this would indicate that EspFU associates
with that protein first.
A.6.2.2 IRTKS versus IRSp53?
Both IRTKS and IRSp53 have been reported to link EspFU to Tir [125, 128] in
actin pedestal formation. The disparate results of different labs may simply be due to
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differences in cell type or lines used in their respective studies. Proteomic mass spec
analysis of EspFU-APEX labeled cell lysates may confirm the relative roles of IRTKS
and IRSp53 in EspFU recruitment during actin pedestal formation in different cell
types.
A.6.3 Aim 3: Demonstrate that APEX can provide new information on
unknown functions of effectors
APEX can be used in TEM for single molecule intracellular localization as well
as in mass spec for proteomic analysis by promiscuous biotinylation. Both of these
techniques performed at various timepoints in a variety of biological samples may
give valuable information about other unknown functions and behaviors of EspFU.
A.6.3.1 Other binding partners?
Proteomic mass spec analysis of cell lysates infected with EHEC strains deliver-
ing EspFU-APEX has the potential to be noisy given that the fusion protein may
encounter and label non-specific interactions or non-binding proteins within close
proximity. However, the frequency of labeling individual proteins may be used as
a threshold for true interactions. Labeling frequency of known binding partners
(namely N-WASP and IRTKS) may be useful in determining a fair threshold level.
Heavy isotope or radiolabeling of bacterial cultures in prior to infection may allow for
distinguishing new protein-protein interactions between EspFU and other bacterial
effectors.
A.6.3.2 Mitochondrial association?
EspFU can localize to the mitochondria via targeting sequences in its N-terminal
domain (unpublished data by Alenka Lovy, Tufts University, and other groups).
TEM labeling of APEX may shed light on the degree, timing and frequency of
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this localization compared to localization at actin pedestals. Both TEM and mass
spec analysis would also provide information on whether EspFU enters the inner
mitochondrial compartment.
A.6.3.3 Tight junction disruption?
EspFU has also been reported to complement EPEC in [126]. Direct targeting
to tight junctional structures and proteins may also be seen by TEM and mass spec
proteomic analysis.
A.6.3.4 What’s the difference between non-polarized and polarized cells?
We speculate that structural differences in the cellular architecture between non-
polarized and polarized intestinal cell cultures contribute to the increase in number
of P domains required for successful EspFU recruitment to the IRTKS/Tir complex.
Proteomic mass spec analysis of EspFU-APEX labeled cell lysates from non-polarized
and polarized cells may show differences in the presence and abundance of host
proteins underneath sites of bacterial attachment that may be contributing to this
phenotype.
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APPENDIX B
N-WASP INDEPENDENT PEDESTAL FORMATION BY
EHEC
B.1 Introduction
A minor pathway for EHEC pedestal formation was observed when the KC12
strain was used to infect MEFs deficient for N-WASP [124]. For less than 5% per-
cent for attached bacteria, pedestals were apparent on N-WASP-/- MEFs infected
with KC12 complemented with EspFU; none were observed without EspFU comple-
mentation. Pedestal activity depended on the number of EspFU repeats. However,
the repeat sequence used in the Vingadassalom et al. study do not match the EspFU
repeat sequence used in the current study. Whether this minor pathway contributes
to actin pedestal formation in polarized intestinal cells is unclear.
B.2 Materials and Methods
B.2.1 Cell culture
MEFs were cultured like HeLa cells as described in section 3.3.1.
B.2.2 Stable shRNA knockdown of N-WASP in HCT8 cells
Plasmids expressing shRNA sequences targeted against N-WASP (code #’s 258,
163, 86, 84, and 83) in the pSMC2 vector were ordered from OpenBioSystems (a
prior incarnation of the current UMMS RNAi core) and transfected into subcon-
fluent HCT8 cells using Arrest-In transfection reagent and Opti-MEM according to
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manufacturers’ instructions. Transfected HCT8 cells were subjected to selection un-
der 1 µg/mL of puromycin 24 hours after transfection. Cells surviving 4 days of
selection were seeded at low confluence into 96-well tissue culture plates in an at-
tempt to isolate clonal populations and cells were kept under puromycin selection
during culture.
B.2.3 Bacterial strains and infection
KC12 strains complemented with various mutations of EspFU were cultured for
infection as described in section 3.3.4. Infection was carried out for 3 to 3.5 hours
infection.
B.2.4 Immunofluorescent staining and imaging
Infect cells were processed for immunofluorescence imaging as described in section
3.3.6. Images with acquired using a DeltaVision microscope system with deconvolu-
tion.
B.3 Results
B.3.1 shRNA knock down of N-WASP in HCT8
Creation of stable N-WASP knock down lines of HCT8 were attempted to ad-
dress the role of the N-WASP independent pathway in actin pedestal formation in
polarized intestinal cells. Combinations of 3, 4, and 5 shRNA sequences were used to
generate knockdown lines. Lines that survived puromycin selection were expanded
and screened for N-WASP activity. Since EPEC relies on N-WASP in all of its known
pedestal formation pathways, actin pedestal formation after EPEC infection was used
as a functional screening assay for the degree of functional N-WASP knockdown. Un-
fortunately, no lines prevented EPEC actin pedestal formation upon infection (data
not shown).
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B.3.2 Actin pedestal formation by EspFU truncation and three repeat
mutants in N-WASP -/- MEFs
Given the lack of a good functional knockdown in HCT8 cells, N-WASP-/- MEFs
were used to investigate the possible involvement of the N-WASP independent path-
way in polarized HCT8 cells. The requirement for more EspFU repeats for actin
pedestal formation in N-WASP deficient cells may parallel the conditions in polar-
ized HCT8 cells that lead to an increase in the number of P domains needed for
actin pedestal formation. Table B.1 summarizes the results of infection of wildtype
and N-WASP -/- MEFs by KC12 strains complemented with every EspFU construct
studied in the previous chapters.
Table B.1: N-WASP Independent Actin Pedestal Pathway
Strain EspFU
Foci
in WT
MEF
Pedestals
in WT
MEF
EspFU
Foci in
NW-/-
MEF
Pedestals
in NW-
/- MEF
KC12 + pEspFU Yes Yes Yes Yes
KC12 + HP No No No No
KC12 + HPH No No No No
KC12 + PHP Yes Yes No No
KC12 + HPHP Yes Yes No No
KC12 + HPHPH Yes Yes No No
KC12 + HPHPHP Yes Yes V. weak No/Yes
KC12 + H*PH*PH*P Yes No Yes No
KC12 + HP*HP*HP* No No No No
Continued on the next page
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Strain EspFU
Foci
in WT
MEF
Pedestals
in WT
MEF
EspFU
Foci in
NW-/-
MEF
Pedestals
in NW-
/- MEF
KC12 + H*PHPHP Yes Yes V. weak V. weak
KC12 + HPH*PHP Yes Yes V. weak V. weak
KC12 + HPHPH*P Yes Yes V. weak V. weak
KC12 + HPH*PH*P Yes Yes Yes No
KC12 + H*PHPH*P Yes Yes Yes No
KC12 + H*PH*PHP Yes Yes No/Yes No/Yes
KC12 + HP*HPHP Yes Yes No No
KC12 + HPHP*HP Yes Yes No No
KC12 + HPHPHP* Yes Yes No No
KC12 + HPHP*HP* Weak Weak No No
KC12 + HP*HPHP* Weak Weak No No
KC12 + HP*HP*HP No No No No
B.4 Conclusions
The pattern of minor actin pedestal activity observed in N-WASP-/- cells infected
with strains delivering the various EspFU mutants studied in Chapter 3 does not
correlate well with the EspFU domain requirement phenotype observed in polarized
cells.
The construct HPHPHP was only weakly recruited to sites of bacterial attach-
ment in N-WASP -/- cells and actin pedestal formation was unclear and consis-
tently reproducible between experiments. This contrasts to infection in polarized
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cells where recruitment of HPHPHP is strong and actin pedestals are usually as
robust as that made by full length EspFU.
The control EspFU mutants H*PH*PH*P and HP*HP*HP* showed the expected
patterns of recruitment and pedestal formation in both wildtype and N-WASP -/-
MEFs. Neither construct could generate actin pedestals in either cell type, but
H*PH*PH*P was readily recruited to sites of bacterial attachment.
However, mutant sets with L12A mutations in one or two H domains resulted in
unexpected EspFU recruitment and actin pedestal phenotypes in N-WASP deficient
cells. Mutants with one L12A mutation in one H domain displayed an attenuated
recruitment phenotype, despite having three wildtype P domains (in contrast to
H*PH*PH*P). And two out of three mutants with two L12A mutations in two H
domains displayed no attenuation in recruitment but did not produce actin pedestals.
While mutant sets with W33A mutations in one or two P domains resulted in a
recruitment and actin pedestal phenotype in N-WASP -/- cells that similar to the
phenotype seen in polarized HCT8 cells, it is clear how the absence of N-WASP
should affect recruitment of these constructs to IRTKS via P domains. The results
from this set of mutants might suggest that N-WASP actually contributes to proper
localization of EspFU to IRTKS. However, the construct H*PH*PH*P was recruited
to sites of bacterial attachment clearly without the ability to bind and activate N-
WASP. An alternative hypothesis is that N-WASP somehow makes the intracellular
environment more permissible to EspFU IRTKS binding.
The identity of factors involved in the N-WASP independent pathway are also as
yet unknown, which limits interpretation of these results. Based on known studies
(only one [124]) and our observations, it is unclear what role (if any) the N-WASP
independent pathway plays in polarized intestinal cells during actin pedestal forma-
tion.
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APPENDIX C
TABLES
Table C.1: Bacterial Strains used in this study
Strain
ID
Description Source
CYL1 EHEC strain TUV-93.0 Lab stock [18]
CYL2 EPEC strain JPN15 Lab stock
CYL85 EHEC∆dam ∆espFU This study
CYL96 EHEC∆dam∆espFU + pCL15(HPHPHP) This study
CYL154 EHEC∆dam ∆espFU + pCL1 (HP) This study
CYL157 EHEC∆dam ∆espFU + pCL2 (HPH) This study
CYL160 EHEC∆dam ∆espFU + pCL12 (PHP) This study
CYL163 EHEC∆dam ∆espFU + pCL14 (HPHP) This study
CYL166 EHEC∆dam ∆espFU + pCL20 (HPHPH) This study
CYL172 EHEC∆dam ∆espFU + pKC471 (EspFU) This study
CYL175 EHEC∆dam ∆espFU + pCL39 (H*PHPHP) This study
CYL178 EHEC∆dam ∆espFU + pCL42 (HPH*PHP) This study
CYL181 EHEC∆dam ∆espFU + pCL44 (HPHPH*P) This study
CYL184 EHEC∆dam ∆espFU + pCL25 (HP*HPHP) This study
CYL187 EHEC∆dam ∆espFU + pCL31 (HPHP*HP) This study
Continued on the next page
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Strain
ID
Description Source
CYL190 EHEC∆dam ∆espFU + pCL35 (HPHPHP*) This study
CYL219 EHEC∆dam ∆espFU + pCL55 (HPH*PH*P) This study
CYL222 EHEC∆dam ∆espFU + pCL52 (H*PHPH*P) This study
CYL225 EHEC∆dam ∆espFU + pCL49 (H*PH*PHP) This study
CYL228 EHEC∆dam ∆espFU + pCL64 (HPHP*HP*) This study
CYL231 EHEC∆dam ∆espFU + pCL61 (HP*HPHP*) This study
CYL234 EHEC∆dam ∆espFU + pCL58 (HP*HP*HP) This study
CYL255 EHEC∆dam ∆espFU + pCL73 (HP*H*P*H*P) This study
CYL258 EHEC∆dam ∆espFU + pCL76 (HP*HP*HP*) This study
CYL261 EHEC∆dam ∆espFU + pCL79 (H*PH*PH*P) This study
CYL411 EHEC∆dam ∆espFU + pCL84 (PHPHP) This study
CYL414 EHEC∆dam ∆espFU + pCL87 (PH*PHP) This study
CYL417 EHEC∆dam ∆espFU + pCL90 (PHPH*P) This study
KC12 EPEC ∆Tir-eae::EHEC Tir-eae [21]
KC12 +
pEspFU
EPEC ∆Tir-eae::EHEC Tir-eae + pEspFU [21]
CYL266 KC12 + pCL1 (HP) This study
CYL269 KC12 + pCL2 (HPH) This study
CYL272 KC12 + pCL12 (PHP) This study
CYL275 KC12 + pCL14 (HPHP) This study
CYL278 KC12 + pCL20 (HPHPH) This study
CYL281 KC12 + pCL15 (HPHPHP) This study
Continued on the next page
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Strain
ID
Description Source
CYL290 KC12 + pCL73 (HP*H*P*H*P) This study
CYL293 KC12 + pCL76 (HP*HP*HP*) This study
CYL296 KC12 + pCL79 (H*PH*PH*P) This study
CYL299 KC12 + pCL39 (H*PHPHP) This study
CYL302 KC12 + pCL42 (HPH*PHP) This study
CYL305 KC12 + pCL44 (HPHPH*P) This study
CYL308 KC12 + pCL25 (HP*HPHP) This study
CYL311 KC12 + pCL31 (HPHP*HP) This study
CYL314 KC12 + pCL35 (HPHPHP*) This study
CYL317 KC12 + pCL55 (HPH*PH*P) This study
CYL320 KC12 + pCL52 (H*PHPH*P) This study
CYL323 KC12 + pCL49 (H*PH*PHP) This study
CYL326 KC12 + pCL64 (HPHP*HP*) This study
CYL329 KC12 + pCL61 (HP*HPHP*) This study
CYL332 KC12 + pCL58 (HP*HP*HP) This study
CYL464 EHEC∆dam ∆espFU + pCL93 (HPHPHP-Soy
APEX)
This study
CYL467 EHEC∆dam ∆espFU + pCL98 (HPHPHP-Pea
APEX)
This study
CYL470 EHEC∆dam ∆espFU + pCL105 (EspFU-Soy APEX) This study
CYL472 EHEC∆dam ∆espFU + pCL105 (EspFU-Soy APEX) This study
CYL476 EHEC∆dam ∆espFU + pCL110 (EspFU-Pea APEX) This study
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Table C.2: Primer Table
Primer Name Sequence Use
DAMZeoF 5’-CTGAA GCGCT GGATG CTGTC
GGAGC TTTCT CCACA GCCGG AGAAG
GTGTA ATTAG TTAGT CAGC GGTCA
TGATC AGCAC GTGTT GACAA TTAAT
CATCG G-3
forward primer for
replacement of dam
gene from EHEC
with zeocin cassette
by λ reb recombi-
neering
DAMZeoR 5’-GCAAA ATCAGC CGACA GAATT
GAGGG GGCAA TCAAA TACTG TTTCA
TCCGC TTCTC CTTGA GAATC AGTCC
TGCTC CTCGG CCACG AAGTG CACGC
AGTT-3
reverse primer for
replacement of dam
gene from EHEC
with zeocin cassette
by λ reb recombi-
neering
damF 5’-TCG GTG TTT CTC AAC ACC-3 screening primer for
EHEC ∆dam
damR 5’-CGC TTG TTG TTC AAG CGT-3 screening primer for
EHEC ∆dam
damU 5’-CTG GTC GTT CTC GTC AAT CTT
CTG-3
screening primer for
EHEC ∆dam
damD 5’-AAT CAC CAC GCT GAA GTA TTT
GGC-3
screening primer for
EHEC ∆dam
CLdamF 5’-GTC GGT GTT TCT CAA CAC CGA C-3 screening primer for
EHEC ∆dam
Continued on the next page
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Primer Name Sequence Use
CLdamR 5’-CGA TCT CCG CCA GAT GCG CTT-3 screening primer for
EHEC ∆dam
CLdamU 5’-GAA CCA CGT CTG CGG AAA ATA CT-
3
screening primer for
EHEC ∆dam
CLdamD 5’-CAC TGC GCA TTT CAT CAA TGA C-3 screening primer for
EHEC ∆dam
NEW
SLIM1
5- CCC CCA GCG CCG AAC GCG CCT
GCC CCT ACT CCG CCT GTT CAA AAT
GAA CAG AGC CGC -3
SLIM long for-
ward primer
for HP*HPHP
(*=W33A) mutation
NEW
SLIM2
5- CCT GTT CAA AAT GAA CAG AGC
CGC -3
SLIM short for-
ward primer
for HP*HPHP
(*=W33A) mutation
NEW
SLIM3
5- AAT GTG CTC GGC CAT GTT ACG
TGC -3
SLIM short re-
verse primer
for HP*HPHP
(*=W33A) mutation
NEW
SLIM4
5- CGG AGT AGG GGC AGG CGC GTT
CGG CGC TGG GGG AAT GTG CTC GGC
CAT GTT ACG TGC -3
SLIM long re-
verse primer
for HP*HPHP
(*=W33A) mutation
Continued on the next page
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Primer Name Sequence Use
P2 SLIM1 5-CCG CCG GCG CCT AAT GCG CCT
GCA CCA ACC CCC CCG GTT CAG AAT
GAA CAG TCA CGC-3
SLIM long for-
ward primer
for HPHP*HP
(*=W33A) mutation
P2 SLIM2 5-CCG GTT CAG AAT GAA CAG TCA
CGC-3
SLIM short for-
ward primer
for HPHP*HP
(*=W33A) mutation
P2 SLIM3 5-AAT ATG TTC AGC CAT GTT ACG
AGC-3
SLIM short re-
verse primer
for HPHP*HP
(*=W33A) mutation
P2 SLIM4 5-GGG GGT TGG TGC AGG CGC ATT
AGG CGC CGG CGG AAT ATG TTC AGC
CAT GTT ACG AGC-3
SLIM long re-
verse primer
for HPHP*HP
(*=W33A) mutation
P2 SLIM1 5-CCA CCT GCA CCA AAC GCG CCA
GCT CCG ACA CCT CCA GTG CAG AAT
GAG CAA TCT AGA-3
SLIM long forward
primer for HPH-
PHP* (*=W33A)
mutation
P2 SLIM2 5-CCA GTG CAG AAT GAG CAA TCT
AGA-3
SLIM short forward
primer for HPH-
PHP* (*=W33A)
mutation
Continued on the next page
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Primer Name Sequence Use
P2 SLIM3 5-TAT ATG CTC TGC CAT ATT TCT CGC-
3
SLIM short reverse
primer for HPH-
PHP* (*=W33A)
mutation
P2 SLIM4 5-AGG TGT CGG AGC TGG CGC GTT
TGG TGC AGG TGG TAT ATG CTC TGC
CAT ATT TCT CGC-3
SLIM long reverse
primer for HPH-
PHP* (*=W33A)
mutation
H1 SLIM1 5-GGT ACC TTA CCA GAT GTA GCA CAA
CGT CTT ATG CAA CAT GCT GCT GAA
CAC GGC ATT-3
SLIM long for-
ward primer
for H*PHPHP
(*=L12A) mutation
H1 SLIM2 5-GGT ACC TTA CCA GAT GTA GCA
CAA-3
SLIM short for-
ward primer
for H*PHPHP
(*=L12A) mutation
H1 SLIM3 5-CTC GGC CAT GTT ACG TGC CGG
CTG-3
SLIM short re-
verse primer
for H*PHPHP
(*=L12A) mutation
H1 SLIM4 5-CTC GGC CAT GTT ACG TGC CGG
CTG AAT GCC GTG TTC AGC AGC ATG
TTG CAT AAG ACG-3
SLIM long re-
verse primer
for H*PHPHP
(*=L12A) mutation
Continued on the next page
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Primer Name Sequence Use
H2 SLIM1 5-CGC CCG CTT CCG GAC GTT GCG
CAG CGT TTA ATG CAG CAC GCT GCT
GAA CAT GGG ATT-3
SLIM long for-
ward primer
for HPH*PHP
(*=L12A) mutation
H2 SLIM2 5-CGC CCG CTT CCG GAC GTT GCG
CAG-3
SLIM short for-
ward primer
for HPH*PHP
(*=L12A)
H2 SLIM3 5-TTC AGC CAT GTT ACG AGC TGG
TTG-3
SLIM short re-
verse primer
for HPH*PHP
(*=L12A) mutation
H2 SLIM4 5-TTC AGC CAT GTT ACG AGC TGG
TTG AAT CCC ATG TTC AGC AGC GTG
CTG CAT TAA ACG-3
SLIM long re-
verse primer
for HPH*PHP
(*=L12A) mutation
H3 SLIM1 5-CGC CCA CTA CCT GAT GTC GCT CAG
AGA CTC ATG CAG CAT GCG GCA GAG
CAT GGT ATC-3
SLIM long for-
ward primer
for HPHPH*P
(*=L12A) mutation
H3 SLIM2 5-CGC CCA CTA CCT GAT GTC GCT
CAG-3
SLIM short for-
ward primer
for HPHPH*P
(*=L12A) mutation
Continued on the next page
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Primer Name Sequence Use
H3 SLIM3 5-CTC TGC CAT ATT TCT CGC AGG
CTG-3
SLIM short re-
verse primer
for HPHPH*P
(*=L12A) mutation
H3 SLIM4 5-CTC TGC CAT ATT TCT CGC AGG CTG
GAT ACC ATG CTC TGC CGC ATG CTG
CAT GAG TCT-3
SLIM long re-
verse primer
for HPHPH*P
(*=L12A) mutation
PHPHP
SLIM1
5-CGA CAG TCT ACT GCT GAA AGT
TCG TTA CAT CAA CAA GGT ACC CCG
GCA CGT AAC ATG GCC GAG CAC ATT
CCC CCA GCG CCG AAC TGG-3
SLIM long forward
primer for deletion
for 1st H from HPH-
PHP
PHPHP
SLIM2
5-CCG GCA CGT AAC ATG GCC GAG
CAC ATT CCC CCA GCG CCG AAC TGG-
3
SLIM short forward
primer for deletion
for 1st H from HPH-
PHP
PHPHP
SLIM3
5-ATG AAA TGA TGC CGA ATG GGC
GTT TGG GGC TCG AAA GAG AGT TGT
TGC-3
SLIM short reverse
primer for deletion
for 1st H from HPH-
PHP
PHPHP
SLIM4
5-GGT ACC TTG TTG ATG TAA CGA
ACT TTC AGC AGT AGA CTG TCG ATG
AAA TGA TGC CGA ATG GGC GTT TGG
GGC TCG AAA GAG AGT TGT TGC-3
SLIM long reverse
primer for deletion
for 1st H from HPH-
PHP
Continued on the next page
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Soy-
pCL15
5 GAC ACC TCC AGT GCA GAA TGA
GCA ATC TAG ACC TGG ATC CGG AAA
GTC TTA CCC AAC TGT GAG TGC TGA
TTA CC-3
Forward primer for
overlap extension
PCR of soy APEX
into pCL15
Soy-
pKC471
5 TTG CAG AGC ATG GCA TTA ATA CAT
CTA AGC GCT CGG GAT CCG GAA AGT
CTT ACC CAA CTG TGA GTG CTG ATT
ACC-3
Forward primer for
overlap extension
PCR of soy APEX
into pKC471
Soy-Rev 5- CCG GTA ACT GTC AGG TCA GAG
CTA ATA TAG GTA ATT ATA TTA TAA
TCA CTG CAG TTA GGC ATC AGC AAA
CCC AAG CTC GGA AA-3
Reverse primer for
overlap extension
PCR of soy APEX
into pCL15 or
pKC471
Pea-
pCL15
5 GAC ACC TCC AGT GCA GAA TGA
GCA ATC TAG ACC TGG ATC CGG AAA
GTC ATA CCC AAC CGT GAG CCC AGA
TTA CC-3
Forward primer for
overlap extension
PCR of pea APEX
into pCL15
Pea-
pKC471
5 TTG CAG AGC ATG GCA TTA ATA CAT
CTA AGC GCT CGG GAT CCG GAA AGT
CAT ACC CAA CCG TGA GCC CAG ATT
ACC-3
Forward primer for
overlap extension
PCR of pea APEX
into pKC471
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Pea-Rev 5- CCG GTA ACT GTC AGG TCA GAG
CTA ATA TAG GTA ATT ATA TTA TAA
TCA CTG CAG TTA TGC CTC GGC GAA
TCC CAG TTC AGA CAG-3
Reverse primer
for overlap exten-
sion PCR of pea
APEX into pCL15
or pKC471
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Table C.3: Plasmid Table
Plasmid Name Description Source
pRC/CMV-
3∆CSN
mammalian transfection vector for stable ex-
pression of Calpastat
[94]
pRC/CMV empty mammalian transfection vector control [94]
pKM208 λ red recombinase Kenan Murphy
pDONRZeo Zeocin cassette Lab stock
pDV48 bacterial complementation plasmid expressing
EspFU N-term-5 myc tag
Lab stock
pCL1 bacterial complementation plasmid expressing
EspFU N-term-HP-5 myc tag
This study, created
from pDV48
pCL2 bacterial complementation plasmid expressing
EspFU N-term-HPH-5 myc tag
This study, created
from pDV48
pCL12 bacterial complementation plasmid expressing
EspFU N-term-PHP-5 myc tag
This study, created
from pDV48
HPHPHP minigene encoding HPHPHP in IDTSmart IDT
pCL15 bacterial complementation plasmid expressing
EspFU N-term-HPHPHP-5 myc tag
This study, created
from pDV48
pCL20 bacterial complementation plasmid expressing
EspFU N-term-HPHPH-5 myc tag
This study, created
from pDV48
pCL25 bacterial complementation plasmid expressing
EspFU N-term-HP*HPHP-5 myc tag
This study, created
from pCL15
pCL31 bacterial complementation plasmid expressing
EspFU N-term-HPHP*HP-5 myc tag
This study, created
from pCL15
Continued on the next page
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pCL35 bacterial complementation plasmid expressing
EspFU N-term-HPHPHP*-5 myc tag
This study, created
from pCL15
pCL39 bacterial complementation plasmid expressing
EspFU N-term-H*PHPHP-5 myc tag
This study, created
from pCL15
pCL42 bacterial complementation plasmid expressing
EspFU N-term-HPH*PHP-5 myc tag
This study, created
from pCL15
pCL44 bacterial complementation plasmid expressing
EspFU N-term-HPHPH*P-5 myc tag
This study, created
from pCL15
pCL49 bacterial complementation plasmid expressing
EspFU N-term-H*PH*PHP-5 myc tag
This study, created
from pCL39
pCL52 bacterial complementation plasmid expressing
EspFU N-term-H*PHPH*P-5 myc tag
This study, created
from pCL39
pCL55 bacterial complementation plasmid expressing
EspFU N-term-HPH*PH*P-5 myc tag
This study, created
from pCL44
pCL58 bacterial complementation plasmid expressing
EspFU N-term-HP*HP*HP-5 myc tag
This study, created
from pCL25
pCL61 bacterial complementation plasmid expressing
EspFU N-term-HP*HPHP*-5 myc tag
This study, created
from pCL25
pCL64 bacterial complementation plasmid expressing
EspFU N-term-HPHP*HP*-5 myc tag
This study, created
from pCL35
pCL73 bacterial complementation plasmid expressing
EspFU N-term-HP*H*P*H*P-5 myc tag
This study, created
from pCL67
Continued on the next page
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pCL76 bacterial complementation plasmid expressing
EspFU N-term-HP*HP*HP*-5 myc tag
This study, created
from pCL58
pCL79 bacterial complementation plasmid expressing
EspFU N-term-H*PH*PH*P-5 myc tag
This study, created
from pCL49
pCL84 bacterial complementation plasmid expressing
EspFU N-term-PHPHP-5 myc tag
This study, created
from pCL15
pCL87 bacterial complementation plasmid expressing
EspFU N-term-PH*PHP-5 myc tag
This study, created
from pCL42
pCL90 bacterial complementation plasmid expressing
EspFU N-term-PHPH*P-5 myc tag
This study, created
from pCL44
soy-mito-
APEX
Mitochondria targeted Soy-APEX for promis-
cuous biotinylation
Addgene #42607
pea APEX Cassette for pea APEX for promiscuous bi-
otinylation
Addgene #40306
pKC471 bacterial complementation plasmid expressing
full length EspFU-5 myc tag
Lab strain
pCL93 bacterial complementation plasmid expressing
EspFU-N-term-HPHPHP-Soy APEX
This study, created
from pCL15
pCL98 bacterial complementation plasmid expressing
HPHPHP-Pea APEX
This study, created
from pCL15
pCL105 bacterial complementation plasmid expressing
full length EspFU-Soy APEX
This study, created
from pKC471
Continued on the next page
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pCL108 bacterial complementation plasmid expressing
full length EspFU-Pea APEX
This study, created
from pKC471
pCL110 bacterial complementation plasmid expressing
full length EspFU-Pea APEX
This study, created
from pKC471
pGFP-
Eps8
mammalian expression plasmid producing
GFP-mEps8 on
Giorgio Scita
psPAX2 Lentiviral packaging plasmid producing gag-
pol
Abe Brass (UMMS)
pMD.2G Lentiviral packaging plasmid producing VSV-
G envelope protein
Abe Brass (UMMS)
TRCN0000061543 shRNA against human Eps8 in pLKO.1 UMass shRNA core
TRCN0000061544 shRNA against human Eps8 in pLKO.1 UMass shRNA core
TRCN0000061545 shRNA against human Eps8 in pLKO.1 UMass shRNA core
TRCN0000061546 shRNA against human Eps8 in pLKO.1 UMass shRNA core
TRCN0000061547 shRNA against human Eps8 in pLKO.1 UMass shRNA core
#258 shRNA against human N-WASP in pSMC2 OpenBioSystems
#163 shRNA against human N-WASP in pSMC2 OpenBioSystems
#86 shRNA against human N-WASP in pSMC2 OpenBioSystems
#84 shRNA against human N-WASP in pSMC2 OpenBioSystems
#83 shRNA against human N-WASP in pSMC2 OpenBioSystems
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Table C.4: Antibodies Used
Antibody Vendor Catalog IMF WB
Anti-ezrin Zymed 357300 1:100 1:1000
Anti-O157 Gibco Discontinued
Anti-O157 Fitzgerald In-
dustries
70-XG13
Anti-Myc
(9E10)
Santa Cruz sc-40 1:100 1:500
Anti-Tir Lab generated
sera
1:1000 1:5000
Anti-Eps8 BD 610143 1:100 to
1:1000
1:1000
Anti-IRTKS Novus H00055971-
M01
1:1000 1:1000 to
1:5000
Anti-IRSp53 Novus H00010458-
M01
1:1000 1:1000 to
1:5000
Anti-Tubulin various ven-
dors
1:5000
Anti-GAPDH various ven-
dors
1:5000
Anti-mouse-
Alexa 568
Invitrogen A-11004 1:400
Anti-mouse-
Alexa 488
Invitrogen A10667 1:400
Anti-mouse-
Alexa 647
Invitrogen A31571 1:400
Anti-rabbit-
Alexa 488 or
568
Invitrogen 1:100
Anti-goat-
Alexa 488 or
568
Invitrogen 1:100
Anti-GFP-
Alexa 647
Invitrogen A31852 1:400
Anti-mouse-
HRP
various ven-
dors
1:10,000
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